Breast Cancer Statistics, 2022
This article is the American Cancer Society’s update on female breast cancer statistics in the United States, including population‐based data on incidence, mortality, survival, and mammography screening. Breast cancer incidence rates have risen in most of the past four decades; during the most recen...
Uloženo v:
| Vydáno v: | CA: a cancer journal for clinicians Ročník 72; číslo 6; s. 524 - 541 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Atlanta
Wiley Subscription Services, Inc
01.11.2022
|
| Témata: | |
| ISSN: | 0007-9235, 1542-4863, 1542-4863 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | This article is the American Cancer Society’s update on female breast cancer statistics in the United States, including population‐based data on incidence, mortality, survival, and mammography screening. Breast cancer incidence rates have risen in most of the past four decades; during the most recent data years (2010–2019), the rate increased by 0.5% annually, largely driven by localized‐stage and hormone receptor‐positive disease. In contrast, breast cancer mortality rates have declined steadily since their peak in 1989, albeit at a slower pace in recent years (1.3% annually from 2011 to 2020) than in the previous decade (1.9% annually from 2002 to 2011). In total, the death rate dropped by 43% during 1989–2020, translating to 460,000 fewer breast cancer deaths during that time. The death rate declined similarly for women of all racial/ethnic groups except American Indians/Alaska Natives, among whom the rates were stable. However, despite a lower incidence rate in Black versus White women (127.8 vs. 133.7 per 100,000), the racial disparity in breast cancer mortality remained unwavering, with the death rate 40% higher in Black women overall (27.6 vs. 19.7 deaths per 100,000 in 2016–2020) and two‐fold higher among adult women younger than 50 years (12.1 vs. 6.5 deaths per 100,000). Black women have the lowest 5‐year relative survival of any racial/ethnic group for every molecular subtype and stage of disease (except stage I), with the largest Black–White gaps in absolute terms for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative disease (88% vs. 96%), hormone receptor‐negative/human epidermal growth factor receptor 2‐positive disease (78% vs. 86%), and stage III disease (64% vs. 77%). Progress against breast cancer mortality could be accelerated by mitigating racial disparities through increased access to high‐quality screening and treatment via nationwide Medicaid expansion and partnerships between community stakeholders, advocacy organizations, and health systems. |
|---|---|
| AbstractList | This article is the American Cancer Society’s update on female breast cancer statistics in the United States, including population‐based data on incidence, mortality, survival, and mammography screening. Breast cancer incidence rates have risen in most of the past four decades; during the most recent data years (2010–2019), the rate increased by 0.5% annually, largely driven by localized‐stage and hormone receptor‐positive disease. In contrast, breast cancer mortality rates have declined steadily since their peak in 1989, albeit at a slower pace in recent years (1.3% annually from 2011 to 2020) than in the previous decade (1.9% annually from 2002 to 2011). In total, the death rate dropped by 43% during 1989–2020, translating to 460,000 fewer breast cancer deaths during that time. The death rate declined similarly for women of all racial/ethnic groups except American Indians/Alaska Natives, among whom the rates were stable. However, despite a lower incidence rate in Black versus White women (127.8 vs. 133.7 per 100,000), the racial disparity in breast cancer mortality remained unwavering, with the death rate 40% higher in Black women overall (27.6 vs. 19.7 deaths per 100,000 in 2016–2020) and two‐fold higher among adult women younger than 50 years (12.1 vs. 6.5 deaths per 100,000). Black women have the lowest 5‐year relative survival of any racial/ethnic group for every molecular subtype and stage of disease (except stage I), with the largest Black–White gaps in absolute terms for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative disease (88% vs. 96%), hormone receptor‐negative/human epidermal growth factor receptor 2‐positive disease (78% vs. 86%), and stage III disease (64% vs. 77%). Progress against breast cancer mortality could be accelerated by mitigating racial disparities through increased access to high‐quality screening and treatment via nationwide Medicaid expansion and partnerships between community stakeholders, advocacy organizations, and health systems. This article is the American Cancer Society's update on female breast cancer statistics in the United States, including population-based data on incidence, mortality, survival, and mammography screening. Breast cancer incidence rates have risen in most of the past four decades; during the most recent data years (2010-2019), the rate increased by 0.5% annually, largely driven by localized-stage and hormone receptor-positive disease. In contrast, breast cancer mortality rates have declined steadily since their peak in 1989, albeit at a slower pace in recent years (1.3% annually from 2011 to 2020) than in the previous decade (1.9% annually from 2002 to 2011). In total, the death rate dropped by 43% during 1989-2020, translating to 460,000 fewer breast cancer deaths during that time. The death rate declined similarly for women of all racial/ethnic groups except American Indians/Alaska Natives, among whom the rates were stable. However, despite a lower incidence rate in Black versus White women (127.8 vs. 133.7 per 100,000), the racial disparity in breast cancer mortality remained unwavering, with the death rate 40% higher in Black women overall (27.6 vs. 19.7 deaths per 100,000 in 2016-2020) and two-fold higher among adult women younger than 50 years (12.1 vs. 6.5 deaths per 100,000). Black women have the lowest 5-year relative survival of any racial/ethnic group for every molecular subtype and stage of disease (except stage I), with the largest Black-White gaps in absolute terms for hormone receptor-positive/human epidermal growth factor receptor 2-negative disease (88% vs. 96%), hormone receptor-negative/human epidermal growth factor receptor 2-positive disease (78% vs. 86%), and stage III disease (64% vs. 77%). Progress against breast cancer mortality could be accelerated by mitigating racial disparities through increased access to high-quality screening and treatment via nationwide Medicaid expansion and partnerships between community stakeholders, advocacy organizations, and health systems.This article is the American Cancer Society's update on female breast cancer statistics in the United States, including population-based data on incidence, mortality, survival, and mammography screening. Breast cancer incidence rates have risen in most of the past four decades; during the most recent data years (2010-2019), the rate increased by 0.5% annually, largely driven by localized-stage and hormone receptor-positive disease. In contrast, breast cancer mortality rates have declined steadily since their peak in 1989, albeit at a slower pace in recent years (1.3% annually from 2011 to 2020) than in the previous decade (1.9% annually from 2002 to 2011). In total, the death rate dropped by 43% during 1989-2020, translating to 460,000 fewer breast cancer deaths during that time. The death rate declined similarly for women of all racial/ethnic groups except American Indians/Alaska Natives, among whom the rates were stable. However, despite a lower incidence rate in Black versus White women (127.8 vs. 133.7 per 100,000), the racial disparity in breast cancer mortality remained unwavering, with the death rate 40% higher in Black women overall (27.6 vs. 19.7 deaths per 100,000 in 2016-2020) and two-fold higher among adult women younger than 50 years (12.1 vs. 6.5 deaths per 100,000). Black women have the lowest 5-year relative survival of any racial/ethnic group for every molecular subtype and stage of disease (except stage I), with the largest Black-White gaps in absolute terms for hormone receptor-positive/human epidermal growth factor receptor 2-negative disease (88% vs. 96%), hormone receptor-negative/human epidermal growth factor receptor 2-positive disease (78% vs. 86%), and stage III disease (64% vs. 77%). Progress against breast cancer mortality could be accelerated by mitigating racial disparities through increased access to high-quality screening and treatment via nationwide Medicaid expansion and partnerships between community stakeholders, advocacy organizations, and health systems. |
| Author | Giaquinto, Angela N. Kramer, Joan L. Jemal, Ahmedin Miller, Kimberly D. Newman, Lisa A. Siegel, Rebecca L. Sung, Hyuna Minihan, Adair |
| Author_xml | – sequence: 1 givenname: Angela N. surname: Giaquinto fullname: Giaquinto, Angela N. email: angela.giaquinto@cancer.org organization: American Cancer Society – sequence: 2 givenname: Hyuna orcidid: 0000-0002-8021-5997 surname: Sung fullname: Sung, Hyuna organization: American Cancer Society – sequence: 3 givenname: Kimberly D. orcidid: 0000-0002-2609-2260 surname: Miller fullname: Miller, Kimberly D. organization: American Cancer Society – sequence: 4 givenname: Joan L. surname: Kramer fullname: Kramer, Joan L. organization: Emory University – sequence: 5 givenname: Lisa A. surname: Newman fullname: Newman, Lisa A. organization: New York‐Presbyterian, Weill Cornell Medicine – sequence: 6 givenname: Adair surname: Minihan fullname: Minihan, Adair organization: American Cancer Society – sequence: 7 givenname: Ahmedin surname: Jemal fullname: Jemal, Ahmedin organization: American Cancer Society – sequence: 8 givenname: Rebecca L. orcidid: 0000-0001-5247-8522 surname: Siegel fullname: Siegel, Rebecca L. organization: American Cancer Society |
| BookMark | eNp90M9LwzAUB_AgE9ymF_8AGXgRsTN5SZr2OIu_YOBBPYckvkJG186kRfbf21pPQzyFB5_v4-U7I5O6qZGQc0aXnAPcOmPcEpiS4ohMmRSQiCzlEzKllKokBy5PyCzGDR1mpabk4i6gie2iMLXDsHhtTetj6128WQAFOCXHpakinv2-c_L-cP9WPCXrl8fnYrVOnOCpSMrMWDBKYWZViZCXqACcSz-MsyJD5kCJfp3kllGKygqFgglrpBUpcOb4nFyNe3eh-ewwtnrro8OqMjU2XdSggOaQcwY9vTygm6YLdX9drzhImQuW94qOyoUmxoCldn74W1O3wfhKM6qHwvRQmP4prI9cH0R2wW9N2P-N2Yi_fIX7f6QuVqtizHwDk2p5nQ |
| CitedBy_id | crossref_primary_10_1016_j_clinbiochem_2025_110954 crossref_primary_10_1016_j_tranon_2025_102304 crossref_primary_10_1016_j_phymed_2025_156869 crossref_primary_10_1186_s12962_023_00503_2 crossref_primary_10_1245_s10434_023_14431_1 crossref_primary_10_1109_TMI_2025_3558786 crossref_primary_10_2147_BCTT_S506783 crossref_primary_10_1093_jnci_djaf217 crossref_primary_10_1093_jnci_djae128 crossref_primary_10_2147_CMAR_S486211 crossref_primary_10_1016_j_compbiomed_2024_109639 crossref_primary_10_1007_s00432_023_05423_5 crossref_primary_10_1007_s00432_023_05171_6 crossref_primary_10_17816_RA678422 crossref_primary_10_3390_sports11050102 crossref_primary_10_3390_healthcare12232483 crossref_primary_10_1002_jso_27459 crossref_primary_10_1007_s40614_024_00430_4 crossref_primary_10_23736_S2724_5691_25_10651_5 crossref_primary_10_1002_bcp_70265 crossref_primary_10_1186_s12885_025_14325_3 crossref_primary_10_1016_j_ejmech_2024_116954 crossref_primary_10_1186_s40170_023_00308_0 crossref_primary_10_3390_ijms241713156 crossref_primary_10_1080_14740338_2024_2439510 crossref_primary_10_1016_j_biopha_2024_117264 crossref_primary_10_1007_s10549_024_07265_2 crossref_primary_10_1097_PRS_0000000000010770 crossref_primary_10_3389_fendo_2025_1557858 crossref_primary_10_1016_j_canlet_2025_217865 crossref_primary_10_1177_15330338241288751 crossref_primary_10_12677_wjcr_2025_153016 crossref_primary_10_7554_eLife_103953 crossref_primary_10_3390_jcm12020419 crossref_primary_10_1002_aoc_7363 crossref_primary_10_1093_jnci_djae120 crossref_primary_10_1002_app_54227 crossref_primary_10_1001_jamanetworkopen_2024_56142 crossref_primary_10_1186_s12964_024_02000_2 crossref_primary_10_1016_j_surg_2024_08_047 crossref_primary_10_1007_s00210_023_02903_w crossref_primary_10_3390_jcm12134410 crossref_primary_10_3390_cancers17071059 crossref_primary_10_1007_s13187_025_02645_8 crossref_primary_10_3390_cancers15030681 crossref_primary_10_1007_s12609_024_00556_z crossref_primary_10_15829_1560_4071_2025_5920 crossref_primary_10_3390_cancers15102817 crossref_primary_10_1007_s00542_025_05866_5 crossref_primary_10_1007_s11227_024_06090_0 crossref_primary_10_3390_metabo14120683 crossref_primary_10_1002_cbdv_202400870 crossref_primary_10_1007_s10549_023_06897_0 crossref_primary_10_1002_cam4_6487 crossref_primary_10_3390_cells12131715 crossref_primary_10_1007_s40615_024_02208_5 crossref_primary_10_1186_s12916_024_03638_y crossref_primary_10_1016_j_nutres_2024_04_006 crossref_primary_10_1038_s41698_024_00780_x crossref_primary_10_31083_j_ceog5106138 crossref_primary_10_1039_D4NR01314J crossref_primary_10_1080_22311866_2024_2361684 crossref_primary_10_1186_s12885_024_12815_4 crossref_primary_10_3390_polym15041025 crossref_primary_10_1021_acsabm_5c00789 crossref_primary_10_1177_20552076241257082 crossref_primary_10_3389_fgene_2024_1363896 crossref_primary_10_1002_tox_24120 crossref_primary_10_3390_ijms242216366 crossref_primary_10_3390_jnt4030016 crossref_primary_10_1007_s11051_024_06166_1 crossref_primary_10_1016_j_acra_2023_12_013 crossref_primary_10_1088_2057_1976_adeb91 crossref_primary_10_1016_j_acra_2023_12_005 crossref_primary_10_1039_D3SC00090G crossref_primary_10_1097_MD_0000000000042288 crossref_primary_10_1146_annurev_biodatasci_020722_092748 crossref_primary_10_1245_s10434_025_17857_x crossref_primary_10_57264_cer_2025_0013 crossref_primary_10_2174_0113894501345632241022055444 crossref_primary_10_1007_s11912_024_01553_2 crossref_primary_10_3390_cancers15194720 crossref_primary_10_1016_j_crad_2024_04_021 crossref_primary_10_1080_15592294_2025_2473250 crossref_primary_10_1016_j_jcpo_2024_100467 crossref_primary_10_1007_s12609_024_00521_w crossref_primary_10_1007_s00520_024_08698_7 crossref_primary_10_1007_s00604_023_05989_4 crossref_primary_10_1007_s13187_025_02667_2 crossref_primary_10_1093_jnci_djae329 crossref_primary_10_1007_s10495_023_01904_7 crossref_primary_10_1007_s43152_025_00063_y crossref_primary_10_3390_cancers15041119 crossref_primary_10_1016_j_bioadv_2024_214121 crossref_primary_10_3390_life15010092 crossref_primary_10_1007_s10552_022_01663_x crossref_primary_10_1093_jleuko_qiae190 crossref_primary_10_1158_0008_5472_CAN_24_1359 crossref_primary_10_1038_s12276_025_01430_3 crossref_primary_10_1111_1759_7714_14829 crossref_primary_10_1245_s10434_025_17152_9 crossref_primary_10_1148_rg_230011 crossref_primary_10_1200_OP_24_00655 crossref_primary_10_1038_s41598_024_71439_7 crossref_primary_10_2147_BCTT_S497313 crossref_primary_10_1021_acsami_5c10905 crossref_primary_10_1093_jbi_wbad096 crossref_primary_10_1111_cen_70011 crossref_primary_10_1186_s12967_024_05619_4 crossref_primary_10_1016_j_jcis_2023_05_018 crossref_primary_10_1093_jnci_djae314 crossref_primary_10_3389_fnut_2025_1576043 crossref_primary_10_3390_jpm14090895 crossref_primary_10_1016_j_canlet_2025_217668 crossref_primary_10_1148_rg_230027 crossref_primary_10_1007_s42452_025_07523_y crossref_primary_10_1371_journal_pone_0320727 crossref_primary_10_1245_s10434_024_16805_5 crossref_primary_10_3892_mmr_2023_13118 crossref_primary_10_1021_acscentsci_4c01628 crossref_primary_10_1245_s10434_024_15940_3 crossref_primary_10_1245_s10434_025_16959_w crossref_primary_10_1016_j_isci_2024_110329 crossref_primary_10_1245_s10434_024_15757_0 crossref_primary_10_3390_diagnostics14010104 crossref_primary_10_1001_jamaoncol_2025_0001 crossref_primary_10_3923_ijp_2023_531_536 crossref_primary_10_3389_fonc_2022_1024772 crossref_primary_10_1002_adom_202402758 crossref_primary_10_1002_adfm_202313090 crossref_primary_10_1109_JSEN_2023_3306611 crossref_primary_10_3390_biom15060757 crossref_primary_10_1111_cns_14862 crossref_primary_10_3389_fimmu_2025_1539074 crossref_primary_10_1016_j_jcis_2024_08_195 crossref_primary_10_1158_1940_6207_CAPR_24_0324 crossref_primary_10_3389_fphar_2024_1371346 crossref_primary_10_3390_diagnostics13030537 crossref_primary_10_1007_s10549_024_07515_3 crossref_primary_10_1186_s12935_024_03299_0 crossref_primary_10_3390_cancers15041130 crossref_primary_10_1016_j_heliyon_2023_e15421 crossref_primary_10_1016_j_phytol_2025_02_002 crossref_primary_10_1016_j_surg_2024_08_059 crossref_primary_10_1002_rcs_70055 crossref_primary_10_1007_s00259_023_06508_6 crossref_primary_10_1016_j_jaccao_2024_04_007 crossref_primary_10_1007_s10967_024_09971_z crossref_primary_10_1007_s11523_024_01046_z crossref_primary_10_3389_fphar_2024_1338546 crossref_primary_10_1038_s41598_024_77389_4 crossref_primary_10_1186_s12905_025_03853_6 crossref_primary_10_1097_SAP_0000000000004328 crossref_primary_10_3390_molecules28052058 crossref_primary_10_3389_fphar_2024_1411059 crossref_primary_10_3390_healthcare11101409 crossref_primary_10_1007_s11764_025_01875_5 crossref_primary_10_1186_s12885_024_12269_8 crossref_primary_10_1001_jamanetworkopen_2025_15205 crossref_primary_10_1245_s10434_023_14640_8 crossref_primary_10_1088_1402_4896_addc4b crossref_primary_10_1289_EHP13882 crossref_primary_10_1001_jamanetworkopen_2024_58141 crossref_primary_10_3390_ijms252313165 crossref_primary_10_1097_01_REO_0000000000000344 crossref_primary_10_1186_s12885_023_10817_2 crossref_primary_10_1007_s00432_024_05810_6 crossref_primary_10_3390_cancers16071433 crossref_primary_10_1080_14737140_2024_2326575 crossref_primary_10_1186_s12889_025_21908_z crossref_primary_10_1007_s10552_023_01667_1 crossref_primary_10_3390_ijerph20065046 crossref_primary_10_1007_s10549_025_07652_3 crossref_primary_10_21597_jist_1288146 crossref_primary_10_1016_j_bjps_2024_01_054 crossref_primary_10_3390_molecules28104175 crossref_primary_10_1080_08923973_2024_2430665 crossref_primary_10_2147_IJWH_S482291 crossref_primary_10_2147_IJN_S460712 crossref_primary_10_1007_s10549_025_07665_y crossref_primary_10_1097_CM9_0000000000002891 crossref_primary_10_1002_cbdv_202300609 crossref_primary_10_3389_fonc_2023_1280416 crossref_primary_10_1002_micr_31185 crossref_primary_10_3390_cancers15143741 crossref_primary_10_3390_medicina61030518 crossref_primary_10_3390_diagnostics13182887 crossref_primary_10_3390_ijms25105258 crossref_primary_10_7759_cureus_42819 crossref_primary_10_3389_fphar_2024_1441105 crossref_primary_10_1016_j_acra_2023_07_021 crossref_primary_10_1016_j_snb_2023_134086 crossref_primary_10_3390_pharmaceutics16050654 crossref_primary_10_1080_21645515_2025_2483022 crossref_primary_10_1002_ijc_34945 crossref_primary_10_2147_IJWH_S483139 crossref_primary_10_1080_02656736_2025_2452927 crossref_primary_10_1093_toxres_tfae011 crossref_primary_10_1111_cas_15957 crossref_primary_10_1080_01443615_2024_2363515 crossref_primary_10_1073_pnas_2507571122 crossref_primary_10_1155_2024_5594542 crossref_primary_10_1016_j_cca_2024_117792 crossref_primary_10_1038_s41467_025_61213_2 crossref_primary_10_2147_BCTT_S495183 crossref_primary_10_1200_PO_24_00841 crossref_primary_10_1093_jncics_pkae129 crossref_primary_10_1093_jbi_wbaf008 crossref_primary_10_1007_s00432_024_05680_y crossref_primary_10_1007_s11654_024_00609_w crossref_primary_10_1177_02841851231215145 crossref_primary_10_1016_j_celrep_2025_115487 crossref_primary_10_1007_s12282_024_01642_x crossref_primary_10_1200_OP_24_00434 crossref_primary_10_1007_s00520_024_08530_2 crossref_primary_10_3390_pharmaceutics15092198 crossref_primary_10_1210_endocr_bqae051 crossref_primary_10_1007_s12282_024_01546_w crossref_primary_10_1038_s41419_025_07615_y crossref_primary_10_1016_j_bspc_2024_106038 crossref_primary_10_3390_cimb46070424 crossref_primary_10_3389_fcell_2023_1182123 crossref_primary_10_1002_cam4_5792 crossref_primary_10_1016_j_amjsurg_2024_116017 crossref_primary_10_1038_s41392_024_01889_y crossref_primary_10_7759_cureus_50203 crossref_primary_10_1186_s12944_023_01930_z crossref_primary_10_1515_hmbci_2024_0066 crossref_primary_10_1177_23814683241236511 crossref_primary_10_1093_jbi_wbaf014 crossref_primary_10_3390_diagnostics15080944 crossref_primary_10_1016_j_heliyon_2024_e31555 crossref_primary_10_1093_jbi_wbad091 crossref_primary_10_1055_s_0043_1776782 crossref_primary_10_1177_15330338241265030 crossref_primary_10_3389_fonc_2023_1125189 crossref_primary_10_1007_s10903_023_01564_4 crossref_primary_10_1186_s13058_024_01923_5 crossref_primary_10_3389_fmolb_2024_1331369 crossref_primary_10_3390_medicina59091576 crossref_primary_10_1093_jncics_pkad067 crossref_primary_10_1093_jncics_pkaf004 crossref_primary_10_1016_j_bmcl_2024_129802 crossref_primary_10_1371_journal_pone_0304483 crossref_primary_10_1002_ardp_202400066 crossref_primary_10_1038_s41598_024_65580_6 crossref_primary_10_3390_ijms242417488 crossref_primary_10_1007_s12687_024_00728_5 crossref_primary_10_1016_j_ejmech_2023_116061 crossref_primary_10_1038_s41467_025_57283_x crossref_primary_10_1177_10998004231215777 crossref_primary_10_1038_s41598_025_12896_6 crossref_primary_10_1177_13591053231214517 crossref_primary_10_1007_s13233_023_00178_x crossref_primary_10_1093_jbi_wbaf025 crossref_primary_10_3389_fphar_2024_1345671 crossref_primary_10_1016_j_jacr_2023_05_003 crossref_primary_10_3390_pharmaceutics15122729 crossref_primary_10_3390_jcm13030915 crossref_primary_10_4254_wjh_v17_i7_106151 crossref_primary_10_3390_diagnostics13101688 crossref_primary_10_1016_j_lfs_2024_123013 crossref_primary_10_3389_fonc_2023_1231683 crossref_primary_10_1007_s10549_024_07339_1 crossref_primary_10_1245_s10434_025_17012_6 crossref_primary_10_1093_oncolo_oyaf034 crossref_primary_10_1088_1361_6560_acf559 crossref_primary_10_1002_cbdv_202400015 crossref_primary_10_14348_molcells_2023_2192 crossref_primary_10_3390_cells14060398 crossref_primary_10_1002_advs_202403592 crossref_primary_10_1049_syb2_70012 crossref_primary_10_1097_NCC_0000000000001262 crossref_primary_10_12968_hmed_2024_0254 crossref_primary_10_1016_j_biomaterials_2024_122763 crossref_primary_10_1007_s12672_024_01448_5 crossref_primary_10_3389_fphar_2024_1496664 crossref_primary_10_2217_fon_2023_0858 crossref_primary_10_1002_biof_2147 crossref_primary_10_1007_s00238_023_02122_9 crossref_primary_10_1177_15347354241226625 crossref_primary_10_1038_s41598_024_51796_z crossref_primary_10_1080_19768354_2024_2315950 crossref_primary_10_3389_fphar_2023_1192434 crossref_primary_10_1016_j_bioactmat_2023_08_021 crossref_primary_10_1080_15384047_2024_2445220 crossref_primary_10_1155_joic_5771672 crossref_primary_10_1080_10799893_2025_2513696 crossref_primary_10_1016_j_clbc_2024_10_010 crossref_primary_10_1016_j_socscimed_2023_116528 crossref_primary_10_1016_j_health_2024_100330 crossref_primary_10_1002_ijc_34748 crossref_primary_10_3390_ijms252312696 crossref_primary_10_3390_cancers15092545 crossref_primary_10_3928_25731777_20230309_12 crossref_primary_10_3389_fendo_2025_1553465 crossref_primary_10_1007_s13534_023_00310_x crossref_primary_10_1148_radiol_241628 crossref_primary_10_1016_j_tsep_2025_103266 crossref_primary_10_1016_j_biomaterials_2024_122511 crossref_primary_10_1038_s41523_023_00578_3 crossref_primary_10_1016_j_ejmech_2023_116009 crossref_primary_10_1016_j_procbio_2023_11_029 crossref_primary_10_1002_bmc_5988 crossref_primary_10_1007_s12282_023_01438_5 crossref_primary_10_1158_0008_5472_CAN_24_2070 crossref_primary_10_3389_pore_2025_1612179 crossref_primary_10_2147_OTT_S400563 crossref_primary_10_1016_j_soc_2023_05_008 crossref_primary_10_3390_cancers16183230 crossref_primary_10_1007_s11886_023_01957_9 crossref_primary_10_1007_s10549_024_07315_9 crossref_primary_10_1109_ACCESS_2024_3356602 crossref_primary_10_1111_jrh_12826 crossref_primary_10_3390_cancers16020296 crossref_primary_10_1002_jmri_28946 crossref_primary_10_3390_ijms252211987 crossref_primary_10_1016_j_surg_2024_06_085 crossref_primary_10_1007_s10549_023_07152_2 crossref_primary_10_3390_ijms24119688 crossref_primary_10_3389_fonc_2024_1393492 crossref_primary_10_3390_cells12151929 crossref_primary_10_1016_j_critrevonc_2025_104624 crossref_primary_10_1016_j_soncn_2023_151452 crossref_primary_10_1186_s13550_024_01080_y crossref_primary_10_1038_s41598_024_67527_3 crossref_primary_10_3389_fphar_2025_1559408 crossref_primary_10_1007_s13258_024_01530_w crossref_primary_10_3390_pathogens12030468 crossref_primary_10_1002_ima_23071 crossref_primary_10_3390_ijerph20095740 crossref_primary_10_1245_s10434_023_14777_6 crossref_primary_10_2174_1573405620666230721124048 crossref_primary_10_1016_j_biopha_2024_116353 crossref_primary_10_3390_ijms232315382 crossref_primary_10_38079_igusabder_1469350 crossref_primary_10_1016_j_ejphar_2025_177410 crossref_primary_10_1080_14737140_2024_2330601 crossref_primary_10_7189_jogh_14_04106 crossref_primary_10_1016_j_prro_2023_12_003 crossref_primary_10_1038_s41598_024_55513_8 crossref_primary_10_1016_j_bioorg_2024_107934 crossref_primary_10_18019_1028_4427_2025_31_2_245_251 crossref_primary_10_1016_j_jcis_2024_12_089 crossref_primary_10_1177_10732748241266788 crossref_primary_10_17116_patol20248602114 crossref_primary_10_1007_s10549_025_07630_9 crossref_primary_10_1093_oncolo_oyae164 crossref_primary_10_1016_j_soncn_2024_151763 crossref_primary_10_1093_jbi_wbad042 crossref_primary_10_3390_diagnostics13030367 crossref_primary_10_1016_j_heliyon_2023_e20798 crossref_primary_10_1097_COC_0000000000001189 crossref_primary_10_1016_j_chempr_2024_01_030 crossref_primary_10_1080_08998280_2024_2376972 crossref_primary_10_1007_s00232_024_00308_1 crossref_primary_10_3390_cancers16030634 crossref_primary_10_1038_s41598_024_54762_x crossref_primary_10_3389_fonc_2023_1067264 crossref_primary_10_64013_bbasr_v2025i1_104 crossref_primary_10_3233_THC_232021 crossref_primary_10_1088_2057_1976_ad5296 crossref_primary_10_1016_j_cpccr_2025_100366 crossref_primary_10_3390_diagnostics13020286 crossref_primary_10_1016_j_jconrel_2024_01_069 crossref_primary_10_4049_jimmunol_2200834 crossref_primary_10_1016_j_breast_2024_103862 crossref_primary_10_1016_j_cpccr_2025_100361 crossref_primary_10_1002_cam4_70297 crossref_primary_10_1007_s00520_024_08594_0 crossref_primary_10_1016_j_clbc_2024_11_015 crossref_primary_10_3390_molecules28114486 crossref_primary_10_1016_j_prp_2022_154279 crossref_primary_10_1038_s41568_023_00604_3 crossref_primary_10_1016_j_colsurfb_2023_113381 crossref_primary_10_3389_fonc_2025_1459914 crossref_primary_10_3389_fphar_2025_1564437 crossref_primary_10_1016_j_healthplace_2023_103090 crossref_primary_10_1186_s12935_024_03541_9 crossref_primary_10_3389_fonc_2024_1374821 crossref_primary_10_2174_0115748855333541240819111638 crossref_primary_10_3390_molecules28155804 crossref_primary_10_1002_cam4_71130 crossref_primary_10_1002_cam4_71132 crossref_primary_10_1038_s43856_025_00930_7 crossref_primary_10_3389_fonc_2024_1255109 crossref_primary_10_1007_s10238_025_01621_2 crossref_primary_10_3389_fimmu_2024_1418025 crossref_primary_10_1186_s12957_024_03444_z crossref_primary_10_1007_s10549_024_07314_w crossref_primary_10_33064_iycuaa2024914268 crossref_primary_10_1186_s12966_024_01644_0 crossref_primary_10_1038_s41598_024_57740_5 crossref_primary_10_1002_cmdc_202400267 crossref_primary_10_1007_s10278_023_00925_7 crossref_primary_10_1007_s40615_025_02636_x crossref_primary_10_1093_aje_kwae413 crossref_primary_10_1111_cbdd_14303 crossref_primary_10_1371_journal_pone_0323892 crossref_primary_10_3390_app132212256 crossref_primary_10_1038_s41523_025_00755_6 crossref_primary_10_1016_j_ejmech_2024_116255 crossref_primary_10_3390_ijms242316607 crossref_primary_10_1007_s11033_024_09272_4 crossref_primary_10_3390_cancers15123075 crossref_primary_10_1109_ACCESS_2024_3461360 crossref_primary_10_4014_jmb_2309_09019 crossref_primary_10_1155_ecc_4510055 crossref_primary_10_1007_s00520_024_09022_z crossref_primary_10_3389_fphys_2023_1256644 crossref_primary_10_1002_SMMD_20220036 crossref_primary_10_1016_j_omton_2025_200965 crossref_primary_10_1002_jvc2_70015 crossref_primary_10_7759_cureus_60761 crossref_primary_10_1186_s12889_023_17405_w crossref_primary_10_1002_ijc_35413 crossref_primary_10_1186_s13046_024_03085_w crossref_primary_10_1186_s12916_023_03163_4 crossref_primary_10_1007_s12247_024_09920_z crossref_primary_10_1038_s41598_024_84039_2 crossref_primary_10_1016_j_clbc_2024_03_003 crossref_primary_10_1016_j_suronc_2025_102188 crossref_primary_10_1080_14728222_2024_2427038 crossref_primary_10_1080_19390211_2022_2144582 crossref_primary_10_1007_s10549_024_07469_6 crossref_primary_10_1038_s41416_024_02588_9 crossref_primary_10_1007_s10549_023_07188_4 crossref_primary_10_1016_j_breast_2024_103833 crossref_primary_10_1007_s10549_024_07565_7 crossref_primary_10_1016_j_bspc_2024_106374 crossref_primary_10_3390_nu16050708 crossref_primary_10_3389_fpubh_2023_1119163 crossref_primary_10_1111_phn_13252 crossref_primary_10_1007_s11357_024_01255_4 crossref_primary_10_1016_j_compbiomed_2024_107939 crossref_primary_10_1016_j_matdes_2024_113270 crossref_primary_10_1007_s12011_023_03987_4 crossref_primary_10_1016_j_jbo_2023_100480 crossref_primary_10_1007_s44343_025_00006_2 crossref_primary_10_3892_mco_2023_2667 crossref_primary_10_1007_s11912_023_01430_4 crossref_primary_10_1093_bib_bbae032 crossref_primary_10_1093_oncolo_oyae217 crossref_primary_10_3390_ijms25137208 crossref_primary_10_1007_s12609_024_00529_2 crossref_primary_10_1007_s12672_024_00919_z crossref_primary_10_3390_cancers16173040 crossref_primary_10_1007_s11864_024_01190_8 crossref_primary_10_3390_cancers16173043 crossref_primary_10_1186_s10020_024_00827_6 crossref_primary_10_1007_s12032_023_02255_8 crossref_primary_10_3390_nu16162644 crossref_primary_10_2147_BCTT_S475199 crossref_primary_10_2147_BCTT_S457548 crossref_primary_10_1001_jamanetworkopen_2025_8862 crossref_primary_10_1093_asj_sjae088 crossref_primary_10_1007_s11547_023_01640_7 crossref_primary_10_1186_s40164_025_00667_y crossref_primary_10_1002_jso_27827 crossref_primary_10_1111_1759_7714_15221 crossref_primary_10_1007_s11912_023_01487_1 crossref_primary_10_1016_j_tranon_2023_101676 crossref_primary_10_1016_j_biopha_2023_115373 crossref_primary_10_1007_s10585_023_10230_w crossref_primary_10_1016_j_greeac_2025_100267 crossref_primary_10_1016_j_bjps_2024_01_033 crossref_primary_10_1016_j_bspc_2024_106596 crossref_primary_10_1111_phn_13467 crossref_primary_10_1007_s40487_023_00225_8 crossref_primary_10_1007_s13187_025_02708_w crossref_primary_10_1136_bmjonc_2024_000675 crossref_primary_10_3389_fonc_2023_1101249 crossref_primary_10_3389_fonc_2023_1218206 crossref_primary_10_3390_s24175747 crossref_primary_10_1016_j_arabjc_2024_105947 crossref_primary_10_1016_j_sajb_2024_01_065 crossref_primary_10_1109_JBHI_2023_3341101 crossref_primary_10_1016_j_phymed_2023_155126 crossref_primary_10_1038_s41598_024_66401_6 crossref_primary_10_1097_NCC_0000000000001506 crossref_primary_10_1016_j_prp_2023_154791 crossref_primary_10_3389_fmed_2023_1200947 crossref_primary_10_1057_s41271_023_00434_5 crossref_primary_10_1245_s10434_024_15794_9 crossref_primary_10_3390_biom14010064 crossref_primary_10_1016_j_clbc_2024_02_006 crossref_primary_10_1016_j_csbj_2024_02_016 crossref_primary_10_1039_D3NR03065B crossref_primary_10_1016_j_ijbiomac_2025_142870 crossref_primary_10_1007_s11427_024_2839_4 crossref_primary_10_52711_0974_360X_2025_00488 crossref_primary_10_1021_acs_organomet_5c00119 crossref_primary_10_1016_j_lfs_2024_122763 crossref_primary_10_1097_GOX_0000000000006274 crossref_primary_10_1186_s12905_023_02734_0 crossref_primary_10_1016_j_cmpb_2024_108481 crossref_primary_10_1186_s12885_024_11854_1 crossref_primary_10_1002_pon_9309 crossref_primary_10_1007_s12672_025_03595_9 crossref_primary_10_1007_s41939_024_00487_3 crossref_primary_10_1007_s10278_025_01392_y crossref_primary_10_1016_j_canlet_2025_217463 crossref_primary_10_1097_01_JAA_0000000000000127 crossref_primary_10_1245_s10434_024_15434_2 crossref_primary_10_3390_ijms25126519 crossref_primary_10_1002_ijc_35223 crossref_primary_10_1038_s41598_025_10498_w crossref_primary_10_1002_mco2_624 crossref_primary_10_1148_radiol_230350 crossref_primary_10_3390_biomedicines12040818 crossref_primary_10_1002_adfm_202413914 crossref_primary_10_1557_s43578_025_01686_5 crossref_primary_10_1097_CJI_0000000000000553 crossref_primary_10_1016_j_asjsur_2024_11_005 crossref_primary_10_3390_pharmaceutics16020223 crossref_primary_10_1007_s40435_025_01642_5 crossref_primary_10_3390_ijms232214389 crossref_primary_10_1021_acs_bioconjchem_5c00145 crossref_primary_10_3390_cancers16162806 crossref_primary_10_1007_s11764_024_01628_w crossref_primary_10_1016_j_semcancer_2023_09_003 crossref_primary_10_1002_jso_27625 crossref_primary_10_1097_MD_0000000000042465 crossref_primary_10_1080_00914037_2025_2492155 crossref_primary_10_1016_j_currproblcancer_2024_101118 crossref_primary_10_1007_s13205_025_04409_z crossref_primary_10_2147_BCTT_S476083 crossref_primary_10_3390_cancers15102765 crossref_primary_10_1016_j_knosys_2023_111187 crossref_primary_10_1073_pnas_2503574122 crossref_primary_10_1007_s00238_025_02322_5 crossref_primary_10_1007_s10549_023_07124_6 crossref_primary_10_3390_diagnostics13061203 crossref_primary_10_12677_aam_2025_143115 crossref_primary_10_1007_s10552_024_01878_0 crossref_primary_10_1016_j_clbc_2023_06_004 crossref_primary_10_3390_biomedicines11102716 crossref_primary_10_1002_jso_27630 crossref_primary_10_1111_jan_16643 crossref_primary_10_1016_j_dyepig_2025_112648 crossref_primary_10_1038_s41598_024_74746_1 crossref_primary_10_1186_s12957_025_03962_4 crossref_primary_10_2217_epi_2023_0332 crossref_primary_10_1177_15330338241264843 crossref_primary_10_1002_iid3_1255 crossref_primary_10_1038_s41392_024_01828_x crossref_primary_10_1245_s10434_023_13103_4 crossref_primary_10_1080_87559129_2025_2528083 crossref_primary_10_1186_s13058_023_01738_w crossref_primary_10_1016_j_annonc_2023_09_3104 crossref_primary_10_1186_s12885_025_13832_7 crossref_primary_10_1038_s41591_024_03267_1 crossref_primary_10_1007_s00259_024_07058_1 crossref_primary_10_1007_s11523_023_00979_1 crossref_primary_10_1001_jamanetworkopen_2023_21388 crossref_primary_10_1007_s12609_024_00562_1 crossref_primary_10_3389_fonc_2023_1272586 crossref_primary_10_1016_j_tranon_2024_101928 crossref_primary_10_1371_journal_pone_0321634 crossref_primary_10_3390_cells13201740 crossref_primary_10_3389_fonc_2023_1153076 crossref_primary_10_1016_j_ijrobp_2024_11_009 crossref_primary_10_1155_2022_2346941 crossref_primary_10_1007_s10549_023_07146_0 crossref_primary_10_1097_SAP_0000000000003984 crossref_primary_10_1016_j_talanta_2024_126428 crossref_primary_10_5306_wjco_v15_i3_391 crossref_primary_10_1038_s41523_024_00614_w crossref_primary_10_1186_s12943_023_01805_y crossref_primary_10_1016_j_bbe_2024_08_007 crossref_primary_10_1245_s10434_024_14957_y crossref_primary_10_1177_10998004241268088 crossref_primary_10_1016_j_ijbiomac_2024_139125 crossref_primary_10_1016_j_molstruc_2024_141176 crossref_primary_10_1364_BOE_563044 crossref_primary_10_1007_s10549_025_07703_9 crossref_primary_10_1039_D5RA00484E crossref_primary_10_1093_jnci_djae172 crossref_primary_10_1186_s13020_023_00764_2 crossref_primary_10_1245_s10434_024_15787_8 crossref_primary_10_3390_microorganisms13071632 crossref_primary_10_1038_s41523_025_00775_2 crossref_primary_10_1002_hsr2_2260 crossref_primary_10_1002_pon_70267 crossref_primary_10_1089_jayao_2024_0039 crossref_primary_10_1080_13880209_2024_2443424 crossref_primary_10_1007_s10549_023_07113_9 crossref_primary_10_3390_cancers16030667 crossref_primary_10_1007_s10903_025_01730_w crossref_primary_10_1007_s10549_025_07801_8 crossref_primary_10_3928_25731777_20230920_02 crossref_primary_10_7759_cureus_63138 crossref_primary_10_1016_j_biopha_2023_114453 crossref_primary_10_1002_ddr_22246 crossref_primary_10_3390_biom13091422 crossref_primary_10_1158_1078_0432_CCR_24_1286 crossref_primary_10_4103_bbrj_bbrj_161_23 crossref_primary_10_1016_j_aimed_2024_09_010 crossref_primary_10_1097_AOG_0000000000005757 crossref_primary_10_1007_s00330_025_11777_w crossref_primary_10_3389_fphar_2023_1289003 crossref_primary_10_1016_j_socscimed_2024_117320 crossref_primary_10_1016_j_jddst_2023_105314 crossref_primary_10_3390_ijms24021799 crossref_primary_10_1016_j_jddst_2024_105614 crossref_primary_10_1002_pon_70013 crossref_primary_10_1007_s12609_024_00540_7 crossref_primary_10_1002_cai2_159 crossref_primary_10_1002_cam4_70719 crossref_primary_10_1186_s13014_023_02297_2 crossref_primary_10_3390_cancers16061118 crossref_primary_10_1007_s11760_023_02976_3 crossref_primary_10_1016_j_bioactmat_2023_04_010 crossref_primary_10_1007_s11033_022_08202_6 crossref_primary_10_1245_s10434_024_15665_3 crossref_primary_10_3390_cancers17101634 crossref_primary_10_1080_24751839_2024_2415033 crossref_primary_10_1097_MD_0000000000037298 crossref_primary_10_7554_eLife_103953_3 crossref_primary_10_1007_s00604_023_05768_1 crossref_primary_10_1021_acsomega_5c05302 crossref_primary_10_1007_s13205_023_03582_3 crossref_primary_10_1186_s12913_024_11213_7 crossref_primary_10_3390_biomedicines13061307 crossref_primary_10_3390_cancers17132105 crossref_primary_10_1007_s12672_025_02282_z crossref_primary_10_1186_s12885_025_14194_w crossref_primary_10_1016_j_cej_2023_145036 crossref_primary_10_2147_BCTT_S491277 crossref_primary_10_1016_j_radonc_2023_109946 crossref_primary_10_1371_journal_pone_0321687 crossref_primary_10_1016_j_canrad_2023_08_007 crossref_primary_10_1016_j_jclinepi_2023_09_015 crossref_primary_10_1089_jpm_2023_0547 crossref_primary_10_1038_s41598_023_48231_0 crossref_primary_10_1186_s12859_024_05679_9 crossref_primary_10_1177_17588359231225039 crossref_primary_10_1038_s41598_024_69009_y crossref_primary_10_1007_s00330_024_11099_3 crossref_primary_10_3389_fphar_2025_1403780 crossref_primary_10_1016_j_prp_2025_155838 crossref_primary_10_1159_000546274 crossref_primary_10_3390_life14111451 crossref_primary_10_1186_s12967_023_03943_9 crossref_primary_10_1016_j_clbc_2025_01_001 crossref_primary_10_1007_s11307_025_01981_x crossref_primary_10_3390_jpm14070711 crossref_primary_10_1016_j_jep_2023_117093 crossref_primary_10_1039_D5RA01800E crossref_primary_10_3390_diagnostics14192144 crossref_primary_10_1136_bmjoq_2023_002482 crossref_primary_10_3389_fphar_2024_1406862 crossref_primary_10_1002_jmri_29014 crossref_primary_10_1245_s10434_024_15789_6 crossref_primary_10_3389_fpubh_2023_1276290 crossref_primary_10_1007_s12609_024_00531_8 crossref_primary_10_3389_fonc_2023_1191660 crossref_primary_10_7717_peerj_16679 crossref_primary_10_3389_fphar_2024_1381478 crossref_primary_10_1007_s11764_025_01750_3 crossref_primary_10_1016_j_gerinurse_2023_10_019 crossref_primary_10_3390_cancers15133431 crossref_primary_10_2147_BCTT_S529794 crossref_primary_10_1001_jamanetworkopen_2025_16468 crossref_primary_10_1109_TMI_2024_3381239 crossref_primary_10_1007_s10552_023_01833_5 crossref_primary_10_1016_j_ajcnut_2025_03_017 crossref_primary_10_18203_2349_3933_ijam20251941 crossref_primary_10_5812_gct_138519 crossref_primary_10_3389_fimmu_2025_1544348 crossref_primary_10_1093_jnci_djae241 crossref_primary_10_2967_jnumed_124_267913 crossref_primary_10_1088_1361_6560_ad953e crossref_primary_10_1002_cam4_70842 crossref_primary_10_1007_s11701_024_01913_x crossref_primary_10_1007_s12609_025_00583_4 crossref_primary_10_1002_ijc_35073 crossref_primary_10_1002_slct_202403773 crossref_primary_10_1007_s10549_024_07460_1 crossref_primary_10_1002_mp_17266 crossref_primary_10_7326_M23_3166 crossref_primary_10_1016_j_ejso_2025_109983 crossref_primary_10_3389_fonc_2024_1505934 crossref_primary_10_1002_cam4_6127 crossref_primary_10_1200_JCO_24_00962 crossref_primary_10_1073_pnas_2420383122 crossref_primary_10_62347_WPUW2205 crossref_primary_10_1016_j_ejca_2023_113358 crossref_primary_10_1200_GO_23_00154 crossref_primary_10_1016_j_fct_2024_114968 crossref_primary_10_1002_cam4_70873 crossref_primary_10_1002_cam4_70637 crossref_primary_10_1158_1078_0432_CCR_24_2825 crossref_primary_10_1001_jamanetworkopen_2024_61639 crossref_primary_10_1016_j_pbiomolbio_2024_02_005 crossref_primary_10_3389_fphar_2023_1274336 crossref_primary_10_1016_j_jpain_2024_104709 crossref_primary_10_1016_j_bbrc_2025_152389 crossref_primary_10_1016_j_cej_2024_158394 crossref_primary_10_1093_jnci_djae254 crossref_primary_10_1177_09731296241285972 crossref_primary_10_2147_IJN_S477652 crossref_primary_10_1001_jamanetworkopen_2025_14036 crossref_primary_10_1007_s12274_023_5581_6 crossref_primary_10_1093_jnci_djae262 crossref_primary_10_1109_ACCESS_2024_3503413 crossref_primary_10_3389_fcell_2023_1221784 crossref_primary_10_1016_j_ctrv_2024_102774 crossref_primary_10_1016_j_ijbiomac_2025_139709 crossref_primary_10_3389_fonc_2023_1305545 crossref_primary_10_1007_s10552_024_01894_0 crossref_primary_10_3390_ijms232415978 crossref_primary_10_1016_j_jconrel_2023_11_024 crossref_primary_10_1093_jnci_djad117 crossref_primary_10_54803_sauhsd_1589761 crossref_primary_10_1038_s41591_024_03359_y crossref_primary_10_1007_s40487_023_00250_7 crossref_primary_10_1016_j_envpol_2024_124975 crossref_primary_10_1002_slct_202404806 crossref_primary_10_1007_s40615_024_02079_w crossref_primary_10_1016_j_ultrasmedbio_2024_07_007 crossref_primary_10_1002_cam4_5694 crossref_primary_10_15446_revfacmed_v72n3_112282 crossref_primary_10_3389_fmed_2023_1087270 crossref_primary_10_4274_dir_2024_242923 crossref_primary_10_1016_j_jss_2024_03_028 crossref_primary_10_3389_fphar_2023_1332539 crossref_primary_10_1134_S1068162024607341 crossref_primary_10_1245_s10434_024_15723_w crossref_primary_10_3390_ijms26031279 crossref_primary_10_1002_jgm_3500 crossref_primary_10_3389_fonc_2024_1422009 crossref_primary_10_1016_j_jddst_2024_106418 crossref_primary_10_1158_0008_5472_CAN_23_0539 crossref_primary_10_1177_20552076231207203 crossref_primary_10_3389_fphar_2025_1594799 crossref_primary_10_1016_j_drup_2024_101126 crossref_primary_10_3390_diagnostics13182966 crossref_primary_10_3389_fnut_2024_1519607 crossref_primary_10_1016_j_rechem_2025_102683 crossref_primary_10_1016_j_phymed_2023_154810 crossref_primary_10_3389_fimmu_2025_1534981 crossref_primary_10_3389_fonc_2023_1230083 crossref_primary_10_1016_j_ijpharm_2024_124314 crossref_primary_10_1186_s40959_025_00364_z crossref_primary_10_1007_s11033_025_10626_9 crossref_primary_10_3390_biomedicines11082300 crossref_primary_10_1002_cncr_35318 crossref_primary_10_3390_cancers16233962 crossref_primary_10_1007_s13353_024_00909_5 crossref_primary_10_1093_bjr_tqae197 crossref_primary_10_1007_s10549_023_07182_w crossref_primary_10_1007_s13596_024_00811_9 crossref_primary_10_1016_j_ceramint_2024_01_382 crossref_primary_10_1007_s12609_023_00503_4 crossref_primary_10_1109_RBME_2024_3357877 crossref_primary_10_1055_s_0044_1785218 crossref_primary_10_1186_s40959_025_00340_7 crossref_primary_10_1007_s10147_024_02492_5 crossref_primary_10_3390_cancers15194879 crossref_primary_10_1007_s00520_025_09606_3 crossref_primary_10_1016_j_microc_2024_110919 crossref_primary_10_1016_j_prro_2024_11_007 crossref_primary_10_1080_07853890_2025_2499027 crossref_primary_10_1158_1940_6207_CAPR_24_0208 crossref_primary_10_1016_j_biomaterials_2023_122395 crossref_primary_10_1038_s41523_024_00654_2 crossref_primary_10_3390_ijms252111492 crossref_primary_10_1186_s12967_025_06559_3 crossref_primary_10_52794_hujpharm_1611956 crossref_primary_10_1007_s00520_025_09256_5 crossref_primary_10_1289_EHP13777 crossref_primary_10_1016_j_critrevonc_2024_104292 crossref_primary_10_1002_cncr_35307 crossref_primary_10_1016_j_clbc_2024_07_011 crossref_primary_10_1016_j_intimp_2023_111026 crossref_primary_10_1002_ctm2_70203 crossref_primary_10_1186_s40359_025_02572_9 crossref_primary_10_1177_03008916251323224 crossref_primary_10_1007_s12609_023_00480_8 crossref_primary_10_1007_s12262_024_04030_z crossref_primary_10_1007_s11886_023_01941_3 crossref_primary_10_1001_jamanetworkopen_2024_49798 crossref_primary_10_1007_s10528_024_10806_5 crossref_primary_10_3390_ijerph21081057 crossref_primary_10_1080_14740338_2023_2203485 crossref_primary_10_3389_fonc_2023_1308854 crossref_primary_10_1371_journal_pone_0321717 crossref_primary_10_1007_s10147_024_02648_3 crossref_primary_10_1039_D3NR03881E crossref_primary_10_3389_fonc_2025_1606116 crossref_primary_10_3390_biomedicines11092557 crossref_primary_10_1038_s41598_025_03592_6 crossref_primary_10_1039_D4RA07228F crossref_primary_10_2147_IJN_S445805 crossref_primary_10_1016_j_ejca_2025_115489 crossref_primary_10_1007_s10552_023_01766_z crossref_primary_10_1007_s12609_023_00518_x crossref_primary_10_1016_j_mtbio_2025_101916 crossref_primary_10_3390_biom15050657 crossref_primary_10_1007_s10943_024_02013_8 crossref_primary_10_1016_j_isci_2023_108218 crossref_primary_10_1039_D4MD00279B crossref_primary_10_1002_pro6_1213 crossref_primary_10_3390_math12121779 crossref_primary_10_1038_s41419_023_05859_0 crossref_primary_10_1177_13591053251317793 crossref_primary_10_3390_ph16070992 crossref_primary_10_1007_s12094_024_03793_x crossref_primary_10_1155_2024_8866756 crossref_primary_10_5888_pcd21_230234 crossref_primary_10_1016_j_healthplace_2025_103488 crossref_primary_10_2174_0113816128291108240613094515 crossref_primary_10_3390_cancers15071936 crossref_primary_10_1109_TMI_2024_3485612 crossref_primary_10_3389_fphar_2024_1511423 crossref_primary_10_1177_2050313X231154996 crossref_primary_10_3390_biomedicines13010123 crossref_primary_10_1038_s41598_025_96716_x crossref_primary_10_7759_cureus_62523 crossref_primary_10_3390_jcm13133966 crossref_primary_10_1080_03772063_2025_2512048 crossref_primary_10_3389_fimmu_2023_1153990 crossref_primary_10_1371_journal_pone_0322154 crossref_primary_10_1007_s10549_023_07160_2 crossref_primary_10_1016_j_molstruc_2024_140673 crossref_primary_10_1007_s12672_025_02640_x crossref_primary_10_1093_jbi_wbae038 crossref_primary_10_1007_s00706_023_03127_7 crossref_primary_10_1177_10732748251335365 crossref_primary_10_1210_jendso_bvac197 crossref_primary_10_3389_fimmu_2024_1397303 crossref_primary_10_3897_folmed_66_e119570 crossref_primary_10_3390_ph16070983 crossref_primary_10_1002_ardp_70060 crossref_primary_10_1016_j_bmc_2024_117958 crossref_primary_10_1109_ACCESS_2025_3586139 crossref_primary_10_1001_jamanetworkopen_2024_46091 crossref_primary_10_3390_cancers15184630 crossref_primary_10_3390_cancers16183152 crossref_primary_10_1016_j_bbagen_2023_130375 crossref_primary_10_1155_2024_9319651 crossref_primary_10_1002_cam4_70230 crossref_primary_10_1016_j_breast_2024_103680 crossref_primary_10_1016_j_seminoncol_2025_152386 crossref_primary_10_1016_j_jsbmb_2025_106683 crossref_primary_10_3390_cancers15112906 crossref_primary_10_1002_cncr_35105 crossref_primary_10_1016_j_microc_2025_113076 crossref_primary_10_3390_nu15214628 crossref_primary_10_1080_02726351_2025_2511857 crossref_primary_10_3390_ijms242216072 crossref_primary_10_1007_s12609_024_00548_z crossref_primary_10_1038_s41392_024_01779_3 crossref_primary_10_1371_journal_pone_0291549 crossref_primary_10_1007_s10549_024_07260_7 crossref_primary_10_1186_s12905_024_03526_w crossref_primary_10_1002_mc_23809 crossref_primary_10_1016_j_jcis_2024_02_103 crossref_primary_10_1186_s40360_025_00887_2 crossref_primary_10_1007_s11042_024_18947_w crossref_primary_10_3390_cancers15041069 crossref_primary_10_1097_MD_0000000000035487 crossref_primary_10_1002_cncr_35337 crossref_primary_10_1080_09603123_2025_2492826 crossref_primary_10_3390_microbiolres15020060 crossref_primary_10_1007_s11030_023_10706_7 crossref_primary_10_1016_j_bcp_2023_115808 crossref_primary_10_1039_D3BM01627G crossref_primary_10_24060_2076_3093_2025_15_3_244_250 crossref_primary_10_3390_cimb46110702 crossref_primary_10_1016_j_compbiomed_2024_109396 crossref_primary_10_1007_s13346_023_01342_7 crossref_primary_10_1007_s11227_025_07077_1 crossref_primary_10_1177_20552076241284771 crossref_primary_10_1136_jitc_2023_007117 crossref_primary_10_1016_j_amepre_2023_10_009 crossref_primary_10_1186_s42492_025_00186_x crossref_primary_10_7717_peerj_19359 crossref_primary_10_3897_folmed_66_e113837 crossref_primary_10_1053_j_semnuclmed_2025_01_008 crossref_primary_10_26599_NBE_2025_9290113 crossref_primary_10_1002_jgm_3584 crossref_primary_10_3390_ijms242417193 crossref_primary_10_3390_cancers16152635 crossref_primary_10_1016_j_jacr_2024_08_001 crossref_primary_10_1007_s00210_025_04407_1 crossref_primary_10_1002_cam4_70015 crossref_primary_10_1091_mbc_E23_02_0055 crossref_primary_10_1038_s41598_024_74608_w crossref_primary_10_1007_s10549_024_07534_0 crossref_primary_10_1007_s11912_023_01472_8 crossref_primary_10_1245_s10434_025_17529_w crossref_primary_10_1007_s40487_024_00280_9 crossref_primary_10_1245_s10434_024_16160_5 crossref_primary_10_1016_j_jsbmb_2024_106575 crossref_primary_10_1093_jamia_ocad251 crossref_primary_10_3390_molecules29010189 crossref_primary_10_1002_cam4_6951 crossref_primary_10_3390_jcm13175321 crossref_primary_10_1016_j_bbrc_2024_151132 crossref_primary_10_3390_ijms241411855 crossref_primary_10_1210_jendso_bvad080 crossref_primary_10_1038_s41388_023_02823_2 crossref_primary_10_1109_ACCESS_2024_3449814 crossref_primary_10_1016_j_annonc_2024_10_824 crossref_primary_10_1007_s10549_025_07631_8 crossref_primary_10_1002_cnr2_1827 crossref_primary_10_1002_puh2_70032 crossref_primary_10_1038_s41598_024_74025_z crossref_primary_10_3390_pharmaceutics17050558 crossref_primary_10_1002_fsn3_3869 crossref_primary_10_1016_j_jacr_2025_01_001 crossref_primary_10_3390_ijms25094620 crossref_primary_10_1038_s41523_024_00696_6 crossref_primary_10_1096_fj_202400634R crossref_primary_10_1245_s10434_023_13177_0 crossref_primary_10_1007_s41542_024_00172_4 crossref_primary_10_1136_jitc_2024_009877 crossref_primary_10_3390_molecules29163770 crossref_primary_10_1016_j_breast_2023_05_002 crossref_primary_10_1080_14789450_2023_2203390 crossref_primary_10_1097_PHM_0000000000002456 crossref_primary_10_3390_cancers15092653 crossref_primary_10_1007_s12672_025_02597_x crossref_primary_10_1007_s12602_024_10288_2 crossref_primary_10_1016_j_colsurfa_2022_130654 crossref_primary_10_1177_20552076241293695 crossref_primary_10_3389_fphar_2023_1283247 crossref_primary_10_1186_s40246_025_00776_z crossref_primary_10_1038_s41571_024_00935_6 crossref_primary_10_1177_18758592241296278 crossref_primary_10_3390_ijms25073956 crossref_primary_10_1001_jamanetworkopen_2024_62365 crossref_primary_10_26599_NR_2025_94907079 crossref_primary_10_1002_cnr2_1841 crossref_primary_10_1016_j_ejmech_2024_116680 crossref_primary_10_3389_fonc_2022_1005083 crossref_primary_10_1186_s12889_024_20592_9 crossref_primary_10_1007_s10549_025_07751_1 crossref_primary_10_1007_s00520_023_08064_z crossref_primary_10_1680_jbibn_24_00004 crossref_primary_10_3389_fonc_2024_1281885 crossref_primary_10_1007_s12672_024_01269_6 crossref_primary_10_3390_ijms25052923 crossref_primary_10_1021_acscentsci_4c02188 crossref_primary_10_3390_ijms24098396 crossref_primary_10_1002_pon_70196 crossref_primary_10_1007_s10549_024_07337_3 crossref_primary_10_1080_15321819_2025_2475291 crossref_primary_10_12998_wjcc_v12_i11_1885 crossref_primary_10_1186_s12880_024_01522_y crossref_primary_10_1093_oncolo_oyae146 crossref_primary_10_1136_bmjopen_2024_088431 crossref_primary_10_1097_CEJ_0000000000000895 crossref_primary_10_7759_cureus_69213 crossref_primary_10_3892_ijo_2024_5631 crossref_primary_10_1371_journal_pone_0318167 crossref_primary_10_1007_s40495_024_00365_z crossref_primary_10_1007_s40336_025_00690_3 crossref_primary_10_1007_s10549_023_07130_8 crossref_primary_10_1021_acs_jafc_5c05537 crossref_primary_10_37549_AR2943 crossref_primary_10_3390_cancers16213640 crossref_primary_10_1016_j_prp_2023_154413 crossref_primary_10_15585_mmwr_mm7315e1 crossref_primary_10_1186_s13058_025_02073_y crossref_primary_10_3892_ijmm_2025_5491 crossref_primary_10_1002_jmri_28713 crossref_primary_10_1007_s12559_023_10214_8 crossref_primary_10_14701_ahbps_24_101 crossref_primary_10_1016_j_cbi_2024_110999 crossref_primary_10_3892_ijo_2024_5644 crossref_primary_10_1007_s11547_024_01838_3 crossref_primary_10_3390_ijms25021063 crossref_primary_10_1016_j_ejrad_2025_112179 crossref_primary_10_1007_s42979_023_02469_7 crossref_primary_10_3390_cancers15153809 crossref_primary_10_7326_ANNALS_24_02229_JC crossref_primary_10_1038_s41586_024_08400_1 crossref_primary_10_1007_s00262_024_03701_w crossref_primary_10_1097_NCC_0000000000001434 crossref_primary_10_1016_j_tcb_2023_03_010 crossref_primary_10_3390_medicina59071338 crossref_primary_10_1007_s00203_023_03632_7 crossref_primary_10_3390_bioengineering10030388 crossref_primary_10_3322_caac_21839 crossref_primary_10_1007_s13346_025_01920_x crossref_primary_10_1109_TIP_2025_3561679 crossref_primary_10_1080_14740338_2023_2288147 crossref_primary_10_1097_QMH_0000000000000513 crossref_primary_10_1007_s12282_024_01634_x crossref_primary_10_3390_ijms24021622 crossref_primary_10_1016_j_actbio_2024_09_035 crossref_primary_10_1371_journal_pone_0296153 crossref_primary_10_1080_08820139_2024_2354264 crossref_primary_10_1080_15592294_2024_2360160 crossref_primary_10_1186_s12885_024_12493_2 crossref_primary_10_1016_j_jncc_2025_02_002 crossref_primary_10_1016_j_jece_2025_115473 crossref_primary_10_2196_53872 crossref_primary_10_1002_jum_16460 crossref_primary_10_3389_fonc_2023_1207867 crossref_primary_10_1007_s11831_025_10341_5 crossref_primary_10_1016_j_bbagen_2023_130542 crossref_primary_10_1111_bjh_19432 crossref_primary_10_3389_fphar_2025_1587675 crossref_primary_10_1126_science_adh8697 crossref_primary_10_1186_s12905_025_03663_w crossref_primary_10_1007_s00761_024_01515_0 crossref_primary_10_1097_NCC_0000000000001423 crossref_primary_10_1016_j_clbc_2025_05_009 crossref_primary_10_1073_pnas_2122053120 crossref_primary_10_1136_bmjopen_2025_104378 crossref_primary_10_1007_s12672_023_00732_0 crossref_primary_10_3390_biomedicines12020280 crossref_primary_10_7759_cureus_70685 crossref_primary_10_1016_j_ijrobp_2024_08_037 crossref_primary_10_1038_s41419_023_06085_4 crossref_primary_10_1093_jbi_wbad003 crossref_primary_10_3322_caac_21820 crossref_primary_10_1177_15330338241234791 crossref_primary_10_1245_s10434_024_15793_w crossref_primary_10_3390_ijms25052728 crossref_primary_10_3389_fpubh_2023_1100421 crossref_primary_10_1186_s12951_024_02644_9 crossref_primary_10_3390_ijms25105109 crossref_primary_10_1002_advs_202501341 crossref_primary_10_1097_COC_0000000000001023 crossref_primary_10_1016_j_bioactmat_2024_08_014 crossref_primary_10_3389_fonc_2024_1356014 crossref_primary_10_1016_j_heliyon_2023_e20475 crossref_primary_10_1080_17501911_2025_2542116 crossref_primary_10_3390_app13084870 crossref_primary_10_1007_s10549_024_07457_w crossref_primary_10_1186_s12967_025_06671_4 crossref_primary_10_3322_caac_21812 crossref_primary_10_3390_cancers17020328 crossref_primary_10_1007_s11357_023_00908_0 crossref_primary_10_1016_j_gene_2024_148258 crossref_primary_10_1016_j_ijbiomac_2023_125362 crossref_primary_10_1186_s12935_025_03810_1 crossref_primary_10_3389_fonc_2023_1130911 crossref_primary_10_3390_nu15071703 crossref_primary_10_1002_ima_23011 crossref_primary_10_4103_aam_aam_101_23 crossref_primary_10_1002_slct_202302465 crossref_primary_10_1186_s41181_023_00235_x crossref_primary_10_3389_fonc_2024_1356001 crossref_primary_10_1039_D5NJ01089F crossref_primary_10_1371_journal_pone_0324655 crossref_primary_10_1007_s12282_023_01517_7 crossref_primary_10_1007_s12094_024_03440_5 crossref_primary_10_3390_cancers16244163 crossref_primary_10_2147_CMAR_S502155 crossref_primary_10_1016_j_molliq_2025_128563 crossref_primary_10_1007_s44337_024_00089_5 crossref_primary_10_1186_s12964_023_01418_4 crossref_primary_10_1002_smtd_202500297 crossref_primary_10_1016_j_saa_2024_124558 crossref_primary_10_3390_cancers15061667 crossref_primary_10_1088_1402_4896_ad7f10 crossref_primary_10_1007_s10549_023_06957_5 crossref_primary_10_1016_j_biopha_2023_116105 crossref_primary_10_1038_s41598_024_51244_y crossref_primary_10_1158_0008_5472_CAN_23_1050 crossref_primary_10_1007_s00432_025_06113_0 crossref_primary_10_1158_1078_0432_CCR_23_1209 crossref_primary_10_1158_0008_5472_CAN_24_0970 crossref_primary_10_1016_j_microc_2024_112538 crossref_primary_10_1039_D5RA03831F crossref_primary_10_1016_j_ejmech_2023_116094 crossref_primary_10_3390_cancers16010087 crossref_primary_10_1097_CCO_0000000000000991 crossref_primary_10_1097_MD_0000000000039511 crossref_primary_10_1016_j_bbamcr_2024_119878 crossref_primary_10_1002_jbio_202400427 crossref_primary_10_1097_GME_0000000000002505 crossref_primary_10_1097_GME_0000000000002504 crossref_primary_10_1055_s_0043_1769937 crossref_primary_10_1097_SAP_0000000000003804 crossref_primary_10_5858_arpa_2023_0576_OA crossref_primary_10_3390_electronics14081571 crossref_primary_10_1245_s10434_023_14296_4 crossref_primary_10_2174_0115734099277605231218071503 crossref_primary_10_1007_s42250_024_01133_8 crossref_primary_10_2196_49197 crossref_primary_10_3390_medicina60010168 crossref_primary_10_1021_acsptsci_5c00133 crossref_primary_10_3390_ijms25063407 crossref_primary_10_1007_s12282_024_01623_0 crossref_primary_10_1016_j_nucmedbio_2024_108961 crossref_primary_10_1186_s13244_023_01492_9 crossref_primary_10_1016_j_colsurfa_2024_133320 crossref_primary_10_1111_imcb_12658 crossref_primary_10_1007_s12672_025_03180_0 crossref_primary_10_3390_cells12121573 crossref_primary_10_1007_s10549_025_07619_4 crossref_primary_10_1002_advs_202309424 crossref_primary_10_1186_s13058_024_01945_z crossref_primary_10_1038_s41392_024_02108_4 crossref_primary_10_62063_rev_22 crossref_primary_10_1371_journal_pone_0302414 crossref_primary_10_3390_ijms24054974 crossref_primary_10_3390_cells14120861 crossref_primary_10_1016_j_jss_2023_11_073 crossref_primary_10_1177_13591053241228437 crossref_primary_10_1016_j_jacr_2024_04_029 crossref_primary_10_1016_j_biopha_2023_115876 crossref_primary_10_1016_j_jds_2024_11_016 crossref_primary_10_1007_s11845_023_03463_x crossref_primary_10_1016_j_clbc_2025_03_017 crossref_primary_10_1007_s12672_024_01676_9 crossref_primary_10_1007_s12672_025_02204_z crossref_primary_10_1080_10410236_2024_2448701 crossref_primary_10_3390_pharmaceutics15102424 crossref_primary_10_1007_s42247_025_01072_1 crossref_primary_10_1177_20552076241297002 crossref_primary_10_3389_fonc_2024_1382986 crossref_primary_10_1016_j_prp_2025_155900 crossref_primary_10_1001_jamaoncol_2025_0178 crossref_primary_10_1038_s41598_024_78958_3 crossref_primary_10_1016_j_tiv_2024_105846 crossref_primary_10_1177_15347354231220617 crossref_primary_10_3390_ijms242216500 crossref_primary_10_1002_iub_2900 crossref_primary_10_3390_catal13101353 crossref_primary_10_1186_s13058_024_01841_6 crossref_primary_10_1245_s10434_025_17448_w crossref_primary_10_1161_CIRCOUTCOMES_124_011504 crossref_primary_10_1002_slct_202300481 crossref_primary_10_1001_jamanetworkopen_2024_41056 crossref_primary_10_1186_s13058_024_01865_y crossref_primary_10_3390_medicina60122099 crossref_primary_10_3389_fendo_2023_1261283 crossref_primary_10_3390_cancers16081494 crossref_primary_10_1016_j_ejmech_2025_117377 crossref_primary_10_3390_jcm13123459 crossref_primary_10_1245_s10434_023_13866_w crossref_primary_10_1016_j_clbc_2025_03_001 crossref_primary_10_3390_cancers15082393 crossref_primary_10_3762_bjnano_15_95 crossref_primary_10_1109_TBME_2024_3372629 crossref_primary_10_1186_s12885_025_13879_6 crossref_primary_10_1016_j_acra_2024_10_036 crossref_primary_10_3390_diagnostics14100984 crossref_primary_10_1016_j_arabjc_2024_106045 crossref_primary_10_3892_ol_2023_14167 crossref_primary_10_3390_biomedicines11102839 crossref_primary_10_1111_jcmm_18212 crossref_primary_10_3389_fonc_2025_1523507 crossref_primary_10_1007_s00521_024_10799_7 crossref_primary_10_1155_tbj_2461234 crossref_primary_10_1016_j_jss_2024_07_026 crossref_primary_10_1049_2024_3786627 crossref_primary_10_3390_math11020406 crossref_primary_10_1038_s41523_025_00774_3 crossref_primary_10_3390_cancers15123118 crossref_primary_10_1186_s12957_024_03485_4 crossref_primary_10_3389_fmed_2025_1606336 crossref_primary_10_1007_s10549_024_07368_w crossref_primary_10_1007_s40487_024_00308_0 crossref_primary_10_1016_j_intimp_2023_111101 crossref_primary_10_1021_acs_jmedchem_5c01092 crossref_primary_10_3389_fphar_2025_1600892 crossref_primary_10_3389_fimmu_2024_1276306 crossref_primary_10_1016_j_jss_2024_04_001 crossref_primary_10_3390_cancers16162906 crossref_primary_10_3390_ijms25179160 crossref_primary_10_3389_fendo_2024_1385756 crossref_primary_10_1016_j_nantod_2025_102816 crossref_primary_10_1016_j_cmpb_2024_108117 crossref_primary_10_1186_s12951_024_02502_8 crossref_primary_10_1097_CM9_0000000000003278 crossref_primary_10_1097_01_REO_0000000000000382 crossref_primary_10_1186_s12885_024_13033_8 crossref_primary_10_1088_2399_1984_acde26 crossref_primary_10_3389_fcvm_2023_1149633 crossref_primary_10_1007_s10549_024_07562_w crossref_primary_10_1186_s12885_025_14249_y crossref_primary_10_1016_j_bioelechem_2025_108944 crossref_primary_10_3390_pharmaceutics15102466 crossref_primary_10_3389_fonc_2024_1406951 crossref_primary_10_3389_fcell_2024_1295403 crossref_primary_10_1002_mco2_70257 crossref_primary_10_1080_14740338_2024_2392011 crossref_primary_10_3390_cancers16203462 crossref_primary_10_1186_s12951_025_03311_3 crossref_primary_10_3390_cancers17081271 crossref_primary_10_1186_s12916_023_03238_2 crossref_primary_10_1007_s12325_024_03074_7 crossref_primary_10_1245_s10434_023_14230_8 crossref_primary_10_1097_MD_0000000000039373 crossref_primary_10_48130_epi_0025_0003 crossref_primary_10_1007_s11547_023_01670_1 crossref_primary_10_4103_jwas_jwas_16_24 crossref_primary_10_1016_j_radcr_2024_09_120 crossref_primary_10_17656_jsmc_10441 crossref_primary_10_1097_SAP_0000000000003857 crossref_primary_10_3389_fimmu_2025_1653970 crossref_primary_10_3389_fonc_2023_1213045 crossref_primary_10_1002_adhm_202401551 crossref_primary_10_1186_s12920_024_02032_0 crossref_primary_10_19161_etd_1681813 crossref_primary_10_3390_cancers17030534 crossref_primary_10_1080_08927022_2024_2333907 crossref_primary_10_3389_fimmu_2024_1368687 crossref_primary_10_3390_biomedicines12061201 crossref_primary_10_3390_ijms25010540 crossref_primary_10_3390_ijms24087235 crossref_primary_10_1016_j_acra_2024_10_018 crossref_primary_10_1016_j_ymeth_2024_10_012 crossref_primary_10_1111_cpr_13650 crossref_primary_10_1007_s00266_024_04107_w crossref_primary_10_1016_j_scitotenv_2024_170773 crossref_primary_10_1002_pon_6370 crossref_primary_10_1016_j_jss_2024_06_025 crossref_primary_10_1093_bjr_tqae129 crossref_primary_10_1016_j_matchemphys_2024_129794 crossref_primary_10_1093_jnci_djae068 crossref_primary_10_3390_healthcare11243185 crossref_primary_10_1097_SAP_0000000000003882 crossref_primary_10_1007_s10549_025_07737_z crossref_primary_10_1002_cpdd_1189 crossref_primary_10_3390_s23031229 crossref_primary_10_1016_j_ctrv_2024_102861 crossref_primary_10_3390_app142411611 crossref_primary_10_1038_s41416_022_02111_y crossref_primary_10_1055_a_2313_0637 crossref_primary_10_1242_dmm_050398 crossref_primary_10_3390_cimb47040250 crossref_primary_10_3389_fgene_2025_1523015 crossref_primary_10_1038_s41598_025_92872_2 crossref_primary_10_1111_cbdd_14637 crossref_primary_10_1016_j_saa_2025_126640 crossref_primary_10_1109_ACCESS_2024_3366185 crossref_primary_10_1186_s12885_023_11122_8 crossref_primary_10_3390_cells13100806 crossref_primary_10_1007_s40261_023_01325_z crossref_primary_10_3390_cancers16203471 crossref_primary_10_1016_j_annonc_2024_04_012 crossref_primary_10_3390_cancers17111781 crossref_primary_10_1002_cncr_34845 crossref_primary_10_1007_s10549_024_07279_w crossref_primary_10_30845_aijss_v13p3 |
| Cites_doi | 10.1016/j.semradonc.2022.01.004 10.3389/fonc.2018.00227 10.1158/1055-9965.EPI-20-1528 10.1007/s10549-017-4229-1 10.1097/PRS.0000000000001276 10.1158/0008-5472.CAN-18-0502 10.1186/s13058-021-01483-y 10.3322/caac.21149 10.1001/jamaoncol.2021.1254 10.3322/caac.21442 10.1016/j.jamcollsurg.2019.12.004 10.1007/s11113-021-09647-6 10.7326/M15-2886 10.1093/jnci/dju289 10.1056/NEJMp2200244 10.1158/1055-9965.EPI-15-0243 10.1056/NEJMra1307118 10.1158/1055-9965.EPI-17-0945 10.1056/NEJMsr070105 10.1002/cncr.33121 10.1093/jnci/djr257 10.1007/s10552-009-9437-5 10.1002/jso.25315 10.1002/cncr.33527 10.1002/cncr.34391 10.1056/NEJMoa1910549 10.1056/NEJMoa2203690 10.1200/JCO.2012.45.2615 10.1007/s10552-016-0793-7 10.1200/OP.20.00831 10.1001/jamaoncol.2017.0595 10.1001/jamasurg.2020.0322 10.3322/caac.21718 10.1056/NEJMoa1804710 10.3322/caac.21703 10.1200/JOP.2017.023333 10.1158/1055-9965.EPI-20-1784 10.1001/jamasurg.2017.0005 10.1007/s10549-018-5042-1 10.1056/NEJMoa2115022 10.1093/jnci/djab186 10.1007/978-0-387-88441-7 10.1093/jnci/djab131 10.1001/jama.2015.12783 10.1007/s10549-022-06547-x 10.1016/j.annonc.2021.06.024 10.1056/NEJMoa050518 10.1093/jncimonographs/lgu016 10.1007/s10549-012-2156-8 10.1016/j.canep.2018.11.006 10.1002/cncr.25679 10.1001/jama.2018.19323 10.1002/cncr.34241 10.1002/cncr.32472 10.1200/JCO.22.00519 10.1001/jamaoncol.2015.3856 10.1001/jamaoncol.2022.0159 10.1158/1055-9965.EPI-20-0924 10.1158/1055-9965.EPI-16-0721 10.3322/caac.21440 10.1001/jama.2017.19130 10.1002/cncr.32293 10.1001/jamasurg.2014.2895 10.1016/j.jss.2020.12.057 10.1200/JCO.2014.57.1349 10.1007/s10549-019-05403-9 10.3322/caac.21695 10.1097/MLR.0000000000000417 10.1093/jnci/djaa148 10.1056/NEJMoa1814017 10.1158/1055-9965.EPI-18-0098 10.1056/NEJMoa1612645 10.3322/caac.21731 10.3322/caac.21388 10.1002/cncr.32207 10.1158/1055-9965.EPI-11-0061 10.1200/JCO.21.02006 10.3322/caac.21708 10.1245/s10434-018-6531-5 10.1200/JCO.2017.73.7932 10.1093/ije/dyl089 10.1001/jamasurg.2018.5113 10.1245/s10434-009-0635-x 10.1080/14728214.2021.1916468 10.1093/jnci/djac158 10.1093/jnci/djv159 10.1001/jama.2014.17322 10.1245/s10434-019-07213-1 10.1200/JCO.20.03399 10.1056/NEJMoa2112651 10.1002/cncr.25542 10.1158/1055-9965.EPI-20-1055 10.1158/1055-9965.EPI-20-1038 10.1093/jnci/djv048 10.1001/jamasurg.2017.0115 10.1007/s10549-020-05545-1 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. Copyright Wiley Subscription Services, Inc. Nov/Dec 2022 2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. |
| Copyright_xml | – notice: 2022 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society. – notice: Copyright Wiley Subscription Services, Inc. Nov/Dec 2022 – notice: 2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. |
| DBID | 24P AAYXX CITATION 3V. 7RV 7T5 7TO 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 K9. KB0 M0S M1P M2O MBDVC NAPCQ P64 PADUT PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U RC3 7X8 |
| DOI | 10.3322/caac.21754 |
| DatabaseName | Wiley Online Library Open Access CrossRef ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Proquest Research Library Research Library (Corporate) ProQuest Nursing and Allied Health Premium Biotechnology and BioEngineering Abstracts Research Library China ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) Research Library China ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Central Basic ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Research Library Prep MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: 7RV name: ProQuest Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Statistics |
| EISSN | 1542-4863 |
| EndPage | 541 |
| ExternalDocumentID | 10_3322_caac_21754 CAAC21754 |
| Genre | article |
| GroupedDBID | .GA .GJ .Y3 0R~ 10A 18M 1CY 1OB 1OC 23N 24P 2WC 31~ 33P 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52P 52R 52S 52T 52X 53G 5GY 5RE 5VS 66C 6J9 6PF 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAHHS AAONW AAWTL AAZKR ABCQN ABEML ACBNA ACCFJ ACCMX ACGFO ACPRK ACSCC ACXQS ADBBV ADIZJ ADPDF ADXAS ADZOD AEEZP AEGXH AEIMD AEQDE AEUQT AFBPY AFFNX AFZJQ AHMBA AI. AIAGR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ATUGU AZBYB BAFTC BAWUL BFHJK BKOMP BY8 C1A CS3 D-6 D-7 D-E D-F DCZOG DIK DR2 E3Z EBD EBS EIHBH EJD EMB EMOBN F00 F01 F04 F5P FAS FJW G-S GODZA GX1 H.X HZ~ IX1 J0M KQ8 L7B LC2 LC3 LH4 LW6 N04 N05 NF~ O66 O9- OHT OK1 OVD P2P P2W P2X P2Z P4E PQQKQ Q.N Q11 QB0 ROL RWI RWL RX1 RXW SJN SUPJJ SV3 TAE TEORI TR2 TWZ UB1 UDS VH1 W2D W8V WH7 WHWMO WIN WOHZO WOQ WQJ WRC WVDHM WXI XG1 XSB XV2 XZL YQJ ZCG ZGI ZVN ZXP ~WT AAFWJ AAYXX CITATION O8X OVT 3V. 7RV 7T5 7TO 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ GUQSH H94 K9. M1P M2O MBDVC NAPCQ P64 PADUT PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQUKI Q9U RC3 7X8 |
| ID | FETCH-LOGICAL-c4364-f8ab2a77e8b7fe29fe722cc6dacb48e1c27420253b100e7b47e414ba5b46231c3 |
| IEDL.DBID | 7RV |
| ISICitedReferencesCount | 1760 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000863250800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-9235 1542-4863 |
| IngestDate | Thu Sep 04 17:43:41 EDT 2025 Mon Oct 06 16:59:49 EDT 2025 Tue Nov 18 21:18:48 EST 2025 Sat Nov 29 06:51:23 EST 2025 Wed Jan 22 16:30:59 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | Attribution-NonCommercial-NoDerivs |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4364-f8ab2a77e8b7fe29fe722cc6dacb48e1c27420253b100e7b47e414ba5b46231c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-5247-8522 0000-0002-8021-5997 0000-0002-2609-2260 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.21754 |
| PQID | 2732559419 |
| PQPubID | 6515 |
| PageCount | 18 |
| ParticipantIDs | proquest_miscellaneous_2720929312 proquest_journals_2732559419 crossref_citationtrail_10_3322_caac_21754 crossref_primary_10_3322_caac_21754 wiley_primary_10_3322_caac_21754_CAAC21754 |
| PublicationCentury | 2000 |
| PublicationDate | November/December 2022 |
| PublicationDateYYYYMMDD | 2022-11-01 |
| PublicationDate_xml | – month: 11 year: 2022 text: November/December 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | Atlanta |
| PublicationPlace_xml | – name: Atlanta |
| PublicationTitle | CA: a cancer journal for clinicians |
| PublicationYear | 2022 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2021; 26 2021; 23 2017; 3 2011; 117 2006; 35 2022; 72 2021; 127 2015; 33 2019; 58 2022; 23 2020; 126 2019; 125 2017; 152 2015; 107 2021; 71 2021; 30 2019; 321 2021; 70 2010; 21 2018; 8 2021; 32 2012; 135 2021; 113 2015; 135 2022; 40 2021; 39 2019; 26 2018; 379 2011; 20 2019; 28 2019; 119 2017; 164 2022; 32 2018; 78 2022; 128 2021; 40 2009; 16 2018; 36 2012; 62 2019; 154 2021; 7 2022; 193 2017; 26 2020; 383 2005; 353 2020; 382 2010 2020; 180 2015; 53 2017; 67 2021; 262 2014; 2014 2017; 376 2022 2022 2019; 380 2018; 27 2016; 164 2018; 25 2018; 68 2022; 114 2007; 356 2022; 386 2015; 24 2022; 387 2011; 103 2015; 150 2016; 2 2015; 314 2022 2015; 313 2021 2020; 230 2021; 17 2022; 8 2013; 31 2017; 13 2019 2017 2020; 155 2018; 319 2015 2014 2019; 173 2016; 27 2019; 178 e_1_2_7_108_1 e_1_2_7_3_1 e_1_2_7_104_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_60_1 e_1_2_7_83_1 e_1_2_7_100_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_64_1 e_1_2_7_87_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_68_1 e_1_2_7_26_1 e_1_2_7_49_1 Arias E (e_1_2_7_24_1) 2021; 70 e_1_2_7_116_1 e_1_2_7_90_1 e_1_2_7_112_1 e_1_2_7_94_1 e_1_2_7_71_1 e_1_2_7_52_1 e_1_2_7_98_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_75_1 e_1_2_7_56_1 e_1_2_7_37_1 Hamilton BE (e_1_2_7_53_1) 2022 e_1_2_7_79_1 e_1_2_7_109_1 e_1_2_7_4_1 e_1_2_7_105_1 e_1_2_7_8_1 e_1_2_7_101_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_82_1 e_1_2_7_63_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_86_1 e_1_2_7_67_1 e_1_2_7_48_1 e_1_2_7_29_1 e_1_2_7_113_1 e_1_2_7_51_1 e_1_2_7_70_1 e_1_2_7_93_1 e_1_2_7_32_1 e_1_2_7_55_1 e_1_2_7_74_1 e_1_2_7_97_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_59_1 e_1_2_7_78_1 e_1_2_7_5_1 e_1_2_7_106_1 e_1_2_7_9_1 e_1_2_7_102_1 e_1_2_7_62_1 e_1_2_7_81_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_66_1 e_1_2_7_85_1 e_1_2_7_47_1 e_1_2_7_89_1 e_1_2_7_28_1 Centers for Disease Control and Prevention (e_1_2_7_17_1) 2019 e_1_2_7_114_1 e_1_2_7_73_1 e_1_2_7_110_1 e_1_2_7_50_1 e_1_2_7_92_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_77_1 e_1_2_7_54_1 e_1_2_7_96_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_58_1 e_1_2_7_39_1 e_1_2_7_6_1 e_1_2_7_107_1 e_1_2_7_80_1 e_1_2_7_103_1 e_1_2_7_18_1 e_1_2_7_84_1 e_1_2_7_61_1 e_1_2_7_2_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_88_1 e_1_2_7_65_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_69_1 e_1_2_7_27_1 e_1_2_7_91_1 e_1_2_7_115_1 e_1_2_7_72_1 e_1_2_7_95_1 e_1_2_7_111_1 e_1_2_7_30_1 e_1_2_7_76_1 e_1_2_7_99_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_57_1 e_1_2_7_38_1 |
| References_xml | – volume: 321 start-page: 288 year: 2019 end-page: 300 article-title: Breast cancer treatment: a review publication-title: JAMA. – volume: 386 start-page: 556 year: 2022 end-page: 567 article-title: Event‐free survival with pembrolizumab in early triple‐negative breast cancer publication-title: N Engl J Med. – start-page: 2022 year: 2022 – volume: 67 start-page: 93 year: 2017 end-page: 99 article-title: The eighth edition AJCC Cancer Staging Manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging publication-title: CA Cancer J Clin. – volume: 313 start-page: 165 year: 2015 end-page: 173 article-title: Differences in breast cancer stage at diagnosis and cancer‐specific survival by race and ethnicity in the United States publication-title: JAMA. – volume: 23 start-page: 2022 year: 2022 publication-title: Published online June – volume: 32 start-page: 1245 year: 2021 end-page: 1255 article-title: Final results from the PERUSE study of first‐line pertuzumab plus trastuzumab plus a taxane for HER2‐positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication publication-title: Ann Oncol. – volume: 135 start-page: 893 year: 2012 end-page: 906 article-title: Receipt of locoregional therapy among young women with breast cancer publication-title: Breast Cancer Res Treat. – volume: 387 start-page: 9 year: 2022 end-page: 20 article-title: Trastuzumab deruxtecan in previously treated HER2‐low advanced breast cancer publication-title: N Engl J Med. – volume: 119 start-page: 79 year: 2019 end-page: 87 article-title: National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer publication-title: J Surg Oncol. – volume: 376 start-page: 2147 year: 2017 end-page: 2159 article-title: Adjuvant capecitabine for breast cancer after preoperative chemotherapy publication-title: N Engl J Med. – volume: 33 start-page: 2254 year: 2015 end-page: 2261 article-title: Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors publication-title: J Clin Oncol. – volume: 150 start-page: 9 year: 2015 end-page: 16 article-title: Nationwide trends in mastectomy for early‐stage breast cancer publication-title: JAMA Surg. – volume: 70 start-page: 1 year: 2021 end-page: 27 article-title: Mortality profile of the non‐Hispanic American Indian or Alaska Native population, 2019 publication-title: Natl Vital Stat Rep. – year: 2022 – volume: 27 start-page: 1139 year: 2016 end-page: 1151 article-title: Metrics for monitoring cancer inequities: residential segregation, the Index of Concentration at the Extremes (ICE), and breast cancer estrogen receptor status (USA, 1992–2012) publication-title: Cancer Causes Control. – volume: 383 start-page: 2557 year: 2020 end-page: 2570 article-title: Systemic therapy for estrogen receptor‐positive, HER2‐negative breast cancer publication-title: N Engl J Med. – volume: 380 start-page: 617 year: 2019 end-page: 628 article-title: Trastuzumab emtansine for residual invasive HER2‐positive breast cancer publication-title: N Engl J Med. – year: 2019 – volume: 173 start-page: 743 year: 2019 end-page: 747 article-title: Trends in stage at diagnosis for young breast cancer patients in the United States publication-title: Breast Cancer Res Treat. – volume: 68 start-page: 7 year: 2018 end-page: 30 article-title: Cancer statistics, 2018 publication-title: CA Cancer J Clin. – volume: 30 start-page: 344 year: 2021 end-page: 350 article-title: Neighborhood social environmental factors and breast cancer subtypes among Black women publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 178 start-page: 433 year: 2019 end-page: 440 article-title: Differences in breast cancer outcomes amongst Black US‐born and Caribbean‐born immigrants publication-title: Breast Cancer Res Treat. – volume: 8 start-page: 227 year: 2018 article-title: Recent advances in the treatment of breast cancer publication-title: Front Oncol. – volume: 107 start-page: djv048 year: 2015 article-title: Annual Report to the Nation on the Status of Cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state publication-title: J Natl Cancer Inst. – volume: 58 start-page: 71 year: 2019 end-page: 76 article-title: The high and heterogeneous burden of breast cancer in Hawaii: a unique multiethnic U.S. population publication-title: Cancer Epidemiol. – volume: 319 start-page: 154 year: 2018 end-page: 164 article-title: Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000–2012 publication-title: JAMA. – volume: 128 start-page: 2728 year: 2022 end-page: 2735 article-title: Racial disparity in distant recurrence‐free survival in patients with localized breast cancer: a pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials publication-title: Cancer. – volume: 125 start-page: 3412 year: 2019 end-page: 3417 article-title: Update on triple‐negative breast cancer disparities for the United States: a population‐based study from the United States Cancer Statistics database, 2010 through 2014 publication-title: Cancer. – volume: 26 start-page: 692 year: 2017 end-page: 701 article-title: The interaction between genetic ancestry and breast cancer risk factors among Hispanic women: the Breast Cancer Health Disparities Study publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 386 start-page: 1143 year: 2022 end-page: 1154 article-title: Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer publication-title: N Engl J Med. – volume: 180 start-page: 437 year: 2020 end-page: 447 article-title: Associations between breast cancer subtype and neighborhood socioeconomic and racial composition among Black and White women publication-title: Breast Cancer Res Treat. – year: 2010 – volume: 126 start-page: 26 year: 2020 end-page: 36 article-title: Male breast cancer in the United States: treatment patterns and prognostic factors in the 21st century publication-title: Cancer. – volume: 68 start-page: 31 year: 2018 end-page: 54 article-title: Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States publication-title: CA Cancer J Clin. – volume: 230 start-page: 331 year: 2020 end-page: 339 article-title: Role of preoperative MRI in the management of newly diagnosed breast cancer patients publication-title: J Am Coll Surg. – volume: 30 start-page: 1416 year: 2021 end-page: 1423 article-title: A pooled case‐only analysis of reproductive risk factors and breast cancer subtype among Black women in the southeastern United States publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 113 start-page: 390 year: 2021 end-page: 399 article-title: Race, ethnicity, and clinical outcomes in hormone receptor‐positive, HER2‐negative, node‐negative breast cancer in the randomized TAILORx trial publication-title: J Natl Cancer Inst. – volume: 154 year: 2019 article-title: Racial differences in time to breast cancer surgery and overall survival in the US military health system publication-title: JAMA Surg. – volume: 40 start-page: 978 year: 2022 end-page: 987 article-title: Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (E2108) publication-title: J Clin Oncol. – volume: 27 start-page: 1214 year: 2018 end-page: 1222 article-title: Proportion of U.S. trends in breast cancer incidence attributable to long‐term changes in risk factor distributions publication-title: Cancer Epidemiol Biomarkers Prev. – year: 2015 article-title: Estrogen receptor status and the future burden of invasive and in situ breast cancers in the United States publication-title: J Natl Cancer Inst. – volume: 28 start-page: 59 year: 2019 end-page: 66 article-title: Multilevel examination of health disparity: the role of policy implementation in neighborhood context, in patient resources, and in healthcare facilities on later stage of breast cancer diagnosis publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 35 start-page: 903 year: 2006 end-page: 919 article-title: Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause‐specific mortality of native‐born and foreign‐born populations in the United States, 1979–2003 publication-title: Int J Epidemiol. – volume: 103 start-page: 1397 year: 2011 end-page: 1402 article-title: Incidence of breast cancer in the United States: current and future trends publication-title: J Natl Cancer Inst. – volume: 114 start-page: 263 year: 2022 end-page: 270 article-title: Decreasing incidence of estrogen receptor‐negative breast cancer in the United States: trends by race and region publication-title: J Natl Cancer Inst. – volume: 7 start-page: 1016 year: 2021 end-page: 1023 article-title: Evaluation of racial/ethnic differences in treatment and mortality among women with triple‐negative breast cancer publication-title: JAMA Oncol. – volume: 40 start-page: 895 year: 2021 end-page: 929 article-title: The immigrant health advantage: an examination of African‐origin Black immigrants in the United States publication-title: Pop Res Policy Rev. – year: 2022 article-title: Estimation of the numbers of individuals living with metastatic cancer in the United States publication-title: J Natl Cancer Inst. – volume: 72 start-page: 202 year: 2022 end-page: 229 article-title: Cancer statistics for African American/Black people 2022 publication-title: CA Cancer J Clin. – volume: 152 start-page: 648 year: 2017 end-page: 657 article-title: State variation in the receipt of a contralateral prophylactic mastectomy among women who received a diagnosis of invasive unilateral early‐stage breast cancer in the United States, 2004–2012 publication-title: JAMA Surg. – volume: 262 start-page: 71 year: 2021 end-page: 84 article-title: Trends in contralateral prophylactic mastectomy utilization for small unilateral breast cancer publication-title: J Surg Res. – volume: 25 start-page: 2241 year: 2018 end-page: 2248 article-title: Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple‐negative and HER2+ subtypes publication-title: Ann Surg Oncol. – volume: 382 start-page: 810 year: 2020 end-page: 821 article-title: Pembrolizumab for early triple‐negative breast cancer publication-title: N Engl J Med. – volume: 71 start-page: 466 year: 2021 end-page: 487 article-title: Cancer statistics for the US Hispanic/Latino population, 2021 publication-title: CA Cancer J Clin. – volume: 126 start-page: 4957 year: 2020 end-page: 4966 article-title: Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women publication-title: Cancer. – volume: 386 start-page: 2349 year: 2022 end-page: 2352 article-title: The emergence of the racial disparity in U.S. breast‐cancer mortality publication-title: N Engl J Med. – year: 2021 – volume: 23 start-page: 108 year: 2021 article-title: Neighborhood disadvantage and individual‐level life stressors in relation to breast cancer incidence in US Black women publication-title: Breast Cancer Res. – volume: 117 start-page: 2209 year: 2011 end-page: 2218 article-title: Update on mammography trends: comparisons of rates in 2000, 2005, and 2008 publication-title: Cancer. – volume: 2014 start-page: 210 year: 2014 end-page: 217 article-title: The impact of follow‐up type and missed deaths on population‐based cancer survival studies for Hispanics and Asians publication-title: J Natl Cancer Inst Monogr. – volume: 16 start-page: 2682 year: 2009 end-page: 2690 article-title: Are mastectomies on the rise? A 13‐year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients publication-title: Ann Surg Oncol. – volume: 26 start-page: 1604 year: 2019 end-page: 1612 article-title: Incident cases captured in the National Cancer Database compared with those in U.S. population based central cancer registries in 2012–2014 publication-title: Ann Surg Oncol. – volume: 78 start-page: 6011 year: 2018 end-page: 6021 article-title: Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype publication-title: Cancer Res. – year: 2022 article-title: . Vital Statistics Rapid Release Report No. 20. Division of Vital Statistics, National Center for Health publication-title: Statistics – volume: 72 start-page: 7 year: 2022 end-page: 33 article-title: Cancer statistics, 2022 publication-title: CA Cancer J Clin. – year: 2022 2022 – volume: 135 start-page: 1518 year: 2015 end-page: 1526 article-title: Bilateral mastectomy versus breast‐conserving surgery for early‐stage breast cancer: the role of breast reconstruction publication-title: Plast Reconstr Surg. – volume: 164 start-page: 139 year: 2017 end-page: 147 article-title: Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes publication-title: Breast Cancer Res Treat. – volume: 36 start-page: 14 year: 2018 end-page: 24 article-title: Factors that contributed to Black‐White disparities in survival among nonelderly women with breast cancer between 2004 and 2013 publication-title: J Clin Oncol. – volume: 164 start-page: 279 year: 2016 end-page: 296 article-title: Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement publication-title: Ann Intern Med. – volume: 314 start-page: 1599 year: 2015 end-page: 1614 article-title: Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society publication-title: JAMA. – volume: 30 start-page: 1387 year: 2021 end-page: 1396 article-title: Cancer mortality disparities among Asian American and Native Hawaiian/Pacific Islander populations in California publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 31 start-page: 2382 year: 2013 end-page: 2387 article-title: Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long‐term follow‐up of CALGB 9343 publication-title: J Clin Oncol. – year: 2014 article-title: Effects of screening and systemic adjuvant therapy on ER‐specific US breast cancer mortality publication-title: J Natl Cancer Inst. – volume: 30 start-page: 53 year: 2021 end-page: 60 article-title: Neighborhood‐level redlining and lending bias are associated with breast cancer mortality in a large and diverse metropolitan area publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 26 start-page: 131 year: 2021 end-page: 147 article-title: Emerging drugs for the treatment of triple‐negative breast cancer: a focus on phase II immunotherapy trials publication-title: Expert Opin Emerg Drugs. – volume: 53 start-page: 872 year: 2015 end-page: 878 article-title: Racial/ethnic disparities in time to a breast cancer diagnosis: the mediating effects of health care facility factors publication-title: Med Care. – volume: 125 start-page: 3401 year: 2019 end-page: 3411 article-title: Breast cancer subtypes among Eastern‐African–born Black women and other Black women in the United States publication-title: Cancer. – volume: 24 start-page: 1039 year: 2015 end-page: 1045 article-title: Breast cancer mortality in African‐American and non‐Hispanic White women by molecular subtype and stage at diagnosis: a population‐based study publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 8 start-page: 863 year: 2022 end-page: 870 article-title: Association of Medicaid expansion with mortality disparity by race and ethnicity among patients with de novo stage IV breast cancer publication-title: JAMA Oncol. – volume: 62 start-page: 220 year: 2012 end-page: 241 article-title: Cancer treatment and survivorship statistics, 2012 publication-title: CA Cancer J Clin. – volume: 379 start-page: 111 year: 2018 end-page: 121 article-title: Adjuvant chemotherapy guided by a 21‐gene expression assay in breast cancer publication-title: N Engl J Med. – volume: 152 start-page: 485 year: 2017 end-page: 493 article-title: Health disparities and triple‐negative breast cancer in African American women: a review publication-title: JAMA Surg. – volume: 17 start-page: 130 year: 2021 end-page: 134 article-title: Navigating Native Hawaiian and Pacific Islander cancer disparities from a cultural and historical perspective publication-title: JCO Oncol Pract. – volume: 353 start-page: 1784 year: 2005 end-page: 1792 article-title: Effect of screening and adjuvant therapy on mortality from breast cancer publication-title: N Engl J Med. – volume: 193 start-page: 21 year: 2022 end-page: 35 article-title: Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies publication-title: Breast Cancer Res Treat. – volume: 13 start-page: 301 year: 2017 end-page: 303 article-title: Triple‐negative breast cancer: current practice and future directions publication-title: J Oncol Pract. – volume: 117 start-page: 180 year: 2011 end-page: 189 article-title: The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care publication-title: Cancer. – volume: 2 start-page: 322 year: 2016 end-page: 329 article-title: Delayed initiation of adjuvant chemotherapy among patients with breast cancer publication-title: JAMA Oncol. – volume: 72 start-page: 112 year: 2022 end-page: 143 article-title: American Cancer Society's report on the status of cancer disparities in the United States, 2021 publication-title: CA Cancer J Clin. – volume: 32 start-page: 221 year: 2022 end-page: 227 article-title: Regional nodal management in the setting of up‐front surgery publication-title: Semin Radiat Oncol. – volume: 3 start-page: 1654 year: 2017 end-page: 1662 article-title: Comparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome Atlas publication-title: JAMA Oncol. – volume: 39 start-page: 1485 year: 2021 end-page: 1505 article-title: Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline publication-title: J Clin Oncol. – volume: 30 start-page: 623 year: 2021 end-page: 642 article-title: Breast cancer risk factors and survival by tumor subtype: pooled analyses from the Breast Cancer Association Consortium publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 20 start-page: 733 year: 2011 end-page: 739 article-title: Breast cancer incidence rates in U.S. women are no longer declining publication-title: Cancer Epidemiol Biomarkers Prev. – volume: 40 start-page: 2612 year: 2022 end-page: 2635 article-title: Systemic therapy for advanced human epidermal growth factor receptor 2‐positive breast cancer: ASCO guideline update publication-title: J Clin Oncol. – volume: 155 start-page: 759 year: 2020 end-page: 770 article-title: Deimplementation of the Choosing Wisely recommendations for low‐value breast cancer surgery: a systematic review publication-title: JAMA Surg. – volume: 21 start-page: 83 year: 2010 end-page: 90 article-title: The impact of changes in hormone therapy on breast cancer incidence in the US population publication-title: Cancer Causes Control. – volume: 127 start-page: 2545 year: 2021 end-page: 2552 article-title: Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: an analysis of the ECOG‐ACRIN TAILORx trial publication-title: Cancer. – volume: 356 start-page: 1670 year: 2007 end-page: 1674 article-title: The decrease in breast cancer incidence in 2003 in the United States publication-title: N Engl J Med. – year: 2017 – volume: 113 start-page: 1648 year: 2021 end-page: 1669 article-title: Annual Report to the Nation on the Status of Cancer, part 1: national cancer statistics publication-title: J Natl Cancer Inst. – ident: e_1_2_7_74_1 doi: 10.1016/j.semradonc.2022.01.004 – year: 2022 ident: e_1_2_7_53_1 article-title: Births: Provisional Data for 2021. Vital Statistics Rapid Release Report No. 20. Division of Vital Statistics, National Center for Health publication-title: Statistics – ident: e_1_2_7_57_1 doi: 10.3389/fonc.2018.00227 – ident: e_1_2_7_28_1 doi: 10.1158/1055-9965.EPI-20-1528 – ident: e_1_2_7_36_1 doi: 10.1007/s10549-017-4229-1 – ident: e_1_2_7_64_1 doi: 10.1097/PRS.0000000000001276 – ident: e_1_2_7_37_1 doi: 10.1158/0008-5472.CAN-18-0502 – ident: e_1_2_7_31_1 doi: 10.1186/s13058-021-01483-y – ident: e_1_2_7_11_1 – ident: e_1_2_7_70_1 doi: 10.3322/caac.21149 – ident: e_1_2_7_105_1 doi: 10.1001/jamaoncol.2021.1254 – ident: e_1_2_7_113_1 doi: 10.3322/caac.21442 – ident: e_1_2_7_68_1 doi: 10.1016/j.jamcollsurg.2019.12.004 – ident: e_1_2_7_111_1 doi: 10.1007/s11113-021-09647-6 – ident: e_1_2_7_116_1 doi: 10.7326/M15-2886 – ident: e_1_2_7_56_1 doi: 10.1093/jnci/dju289 – ident: e_1_2_7_61_1 doi: 10.1056/NEJMp2200244 – ident: e_1_2_7_8_1 – ident: e_1_2_7_101_1 doi: 10.1158/1055-9965.EPI-15-0243 – ident: e_1_2_7_10_1 – ident: e_1_2_7_91_1 doi: 10.1056/NEJMra1307118 – ident: e_1_2_7_58_1 doi: 10.1158/1055-9965.EPI-17-0945 – ident: e_1_2_7_13_1 – ident: e_1_2_7_45_1 doi: 10.1056/NEJMsr070105 – ident: e_1_2_7_59_1 doi: 10.1002/cncr.33121 – ident: e_1_2_7_20_1 doi: 10.1093/jnci/djr257 – ident: e_1_2_7_44_1 doi: 10.1007/s10552-009-9437-5 – ident: e_1_2_7_72_1 doi: 10.1002/jso.25315 – ident: e_1_2_7_109_1 doi: 10.1002/cncr.33527 – ident: e_1_2_7_102_1 doi: 10.1002/cncr.34391 – ident: e_1_2_7_84_1 doi: 10.1056/NEJMoa1910549 – ident: e_1_2_7_92_1 doi: 10.1056/NEJMoa2203690 – ident: e_1_2_7_75_1 doi: 10.1200/JCO.2012.45.2615 – ident: e_1_2_7_34_1 doi: 10.1007/s10552-016-0793-7 – ident: e_1_2_7_27_1 doi: 10.1200/OP.20.00831 – ident: e_1_2_7_42_1 doi: 10.1001/jamaoncol.2017.0595 – ident: e_1_2_7_73_1 doi: 10.1001/jamasurg.2020.0322 – ident: e_1_2_7_2_1 doi: 10.3322/caac.21718 – ident: e_1_2_7_77_1 doi: 10.1056/NEJMoa1804710 – ident: e_1_2_7_30_1 doi: 10.3322/caac.21703 – ident: e_1_2_7_97_1 doi: 10.1200/JOP.2017.023333 – ident: e_1_2_7_52_1 doi: 10.1158/1055-9965.EPI-20-1784 – ident: e_1_2_7_41_1 doi: 10.1001/jamasurg.2017.0005 – ident: e_1_2_7_115_1 – ident: e_1_2_7_51_1 doi: 10.1007/s10549-018-5042-1 – ident: e_1_2_7_90_1 doi: 10.1056/NEJMoa2115022 – ident: e_1_2_7_50_1 doi: 10.1093/jnci/djab186 – ident: e_1_2_7_9_1 – ident: e_1_2_7_7_1 doi: 10.1007/978-0-387-88441-7 – ident: e_1_2_7_47_1 doi: 10.1093/jnci/djab131 – ident: e_1_2_7_23_1 – ident: e_1_2_7_114_1 doi: 10.1001/jama.2015.12783 – ident: e_1_2_7_87_1 doi: 10.1007/s10549-022-06547-x – ident: e_1_2_7_89_1 doi: 10.1016/j.annonc.2021.06.024 – ident: e_1_2_7_55_1 doi: 10.1056/NEJMoa050518 – ident: e_1_2_7_94_1 doi: 10.1093/jncimonographs/lgu016 – ident: e_1_2_7_65_1 doi: 10.1007/s10549-012-2156-8 – ident: e_1_2_7_38_1 doi: 10.1016/j.canep.2018.11.006 – ident: e_1_2_7_43_1 doi: 10.1002/cncr.25679 – ident: e_1_2_7_83_1 doi: 10.1001/jama.2018.19323 – ident: e_1_2_7_98_1 doi: 10.1002/cncr.34241 – volume: 70 start-page: 1 year: 2021 ident: e_1_2_7_24_1 article-title: Mortality profile of the non‐Hispanic American Indian or Alaska Native population, 2019 publication-title: Natl Vital Stat Rep. – ident: e_1_2_7_25_1 doi: 10.1002/cncr.32472 – ident: e_1_2_7_93_1 doi: 10.1200/JCO.22.00519 – ident: e_1_2_7_5_1 – ident: e_1_2_7_107_1 doi: 10.1001/jamaoncol.2015.3856 – ident: e_1_2_7_104_1 doi: 10.1001/jamaoncol.2022.0159 – ident: e_1_2_7_54_1 doi: 10.1158/1055-9965.EPI-20-0924 – ident: e_1_2_7_40_1 doi: 10.1158/1055-9965.EPI-16-0721 – ident: e_1_2_7_21_1 – ident: e_1_2_7_4_1 doi: 10.3322/caac.21440 – ident: e_1_2_7_96_1 doi: 10.1001/jama.2017.19130 – volume-title: Behavioral Risk Factor Surveillance System Survey Data 2019 year: 2019 ident: e_1_2_7_17_1 – ident: e_1_2_7_35_1 doi: 10.1002/cncr.32293 – ident: e_1_2_7_63_1 doi: 10.1001/jamasurg.2014.2895 – ident: e_1_2_7_71_1 doi: 10.1016/j.jss.2020.12.057 – ident: e_1_2_7_100_1 doi: 10.1200/JCO.2014.57.1349 – ident: e_1_2_7_76_1 – ident: e_1_2_7_95_1 doi: 10.1007/s10549-019-05403-9 – ident: e_1_2_7_3_1 doi: 10.3322/caac.21695 – ident: e_1_2_7_62_1 doi: 10.1097/MLR.0000000000000417 – ident: e_1_2_7_78_1 doi: 10.1093/jnci/djaa148 – ident: e_1_2_7_82_1 doi: 10.1056/NEJMoa1814017 – ident: e_1_2_7_48_1 doi: 10.1158/1055-9965.EPI-18-0098 – ident: e_1_2_7_81_1 doi: 10.1056/NEJMoa1612645 – ident: e_1_2_7_14_1 doi: 10.3322/caac.21731 – ident: e_1_2_7_22_1 – ident: e_1_2_7_6_1 doi: 10.3322/caac.21388 – ident: e_1_2_7_29_1 doi: 10.1002/cncr.32207 – ident: e_1_2_7_46_1 doi: 10.1158/1055-9965.EPI-11-0061 – ident: e_1_2_7_88_1 doi: 10.1200/JCO.21.02006 – ident: e_1_2_7_110_1 – ident: e_1_2_7_19_1 doi: 10.3322/caac.21708 – ident: e_1_2_7_79_1 doi: 10.1245/s10434-018-6531-5 – ident: e_1_2_7_103_1 doi: 10.1200/JCO.2017.73.7932 – ident: e_1_2_7_112_1 doi: 10.1093/ije/dyl089 – ident: e_1_2_7_108_1 doi: 10.1001/jamasurg.2018.5113 – ident: e_1_2_7_66_1 doi: 10.1245/s10434-009-0635-x – ident: e_1_2_7_86_1 doi: 10.1080/14728214.2021.1916468 – ident: e_1_2_7_26_1 doi: 10.1093/jnci/djac158 – ident: e_1_2_7_49_1 doi: 10.1093/jnci/djv159 – ident: e_1_2_7_99_1 doi: 10.1001/jama.2014.17322 – ident: e_1_2_7_69_1 – ident: e_1_2_7_16_1 doi: 10.1245/s10434-019-07213-1 – ident: e_1_2_7_80_1 doi: 10.1200/JCO.20.03399 – ident: e_1_2_7_85_1 doi: 10.1056/NEJMoa2112651 – ident: e_1_2_7_18_1 – ident: e_1_2_7_106_1 doi: 10.1002/cncr.25542 – ident: e_1_2_7_32_1 doi: 10.1158/1055-9965.EPI-20-1055 – ident: e_1_2_7_60_1 doi: 10.1158/1055-9965.EPI-20-1038 – ident: e_1_2_7_39_1 doi: 10.1093/jnci/djv048 – ident: e_1_2_7_67_1 doi: 10.1001/jamasurg.2017.0115 – ident: e_1_2_7_12_1 – ident: e_1_2_7_33_1 doi: 10.1007/s10549-020-05545-1 – ident: e_1_2_7_15_1 |
| SSID | ssj0000777 |
| Score | 2.760447 |
| Snippet | This article is the American Cancer Society’s update on female breast cancer statistics in the United States, including population‐based data on incidence,... This article is the American Cancer Society's update on female breast cancer statistics in the United States, including population-based data on incidence,... |
| SourceID | proquest crossref wiley |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 524 |
| SubjectTerms | Black people Breast cancer breast neoplasms Death epidemiology Epidermal growth factor health disparities incidence Mammography Minority & ethnic groups molecular subtype Mortality Statistics Survival Womens health |
| SummonAdditionalLinks | – databaseName: Wiley Online Library Open Access dbid: 24P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFH_MKeLFb7E6R0UvisXmo00LXmZxeHHsoLBbSdL0JJ3Uzb_fl7TbFEQQb4G-NH1fyS95zXsAl5zqwpQFC1Ku4oAXQgdKUh6UEeM0TEuV6sIVmxCjUTKZpOMO3C3uwjT5IZYHbtYz3HxtHVwqV4WEoQ2iErXEARFQR3wN1glhwto05ePVPCxEkzEzFAHCmKhJTmp73676fl-OVhjzK1J1S81w538fuQvbLcT0B41N7EHHVPuw-dQG0Q-gf29_RJ_5mVV47Vu42WRrvvEprrWH8DJ8eM4eg7ZMQqA5i1GsiVRUCmESJUpD09IISrWOC6kVTwzRNhqL0IYpEoZGKC4MJ1zJSHHEPkSzI-hW08ocgx-FOiZJIViJ-mL4LmwaRCioSERGceHB1UJauW5ziNtSFq857iUsy7llOHcMe3CxpH1rMmf8SNVbCD1vvec9R0hldzqcpB6cLx-j3dtghqzMdG5p0JQQqxDqwbVTwS-j5NlgkLnWyV-IT2HLyr25etiD7qyemzPY0B-olrrvrO0TckvTQQ priority: 102 providerName: Wiley-Blackwell |
| Title | Breast Cancer Statistics, 2022 |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.21754 https://www.proquest.com/docview/2732559419 https://www.proquest.com/docview/2720929312 |
| Volume | 72 |
| WOSCitedRecordID | wos000863250800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: 24P dateStart: 19970101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8JAEJ4IGMPFB2pEkdToRWNDu91225OBBqIHkBAf3JruoydTkIe_39m2gCaGi5fNNrvpbr6Z3fm6s50BuKFESJVIxwwo90wqmTB5TKiZuA4lVpDwQMgs2QQbDPzxOBgWB27z4lrlak_MNmo5EfqMvIVmVrNfagcP009TZ43S3tUihUYJKrZuRX1mo7fNTsxYHjPTYiYSGTcPT-qgDrdEjNNFOu7S3wZpwzJ_ctXM2PQO_jvNQ9gvaKbRzvXiCHZUWoO9fuFIr0FVk8w8RvMxNDv6ZvrCCLUGzIxN071B0PiewGuv-xI-mkXeBFNQx0Oc_ZiTmDHlc5YoEiSKESKEJ2PBqa9sod2zyHUcbluWYpwyRW3KY5dTJEO2cE6hnE5SdQaGawnP9iVzEhSgg-_CqkLKgpJFquTJOtyuwItEEVRc57b4iPDjQgMdaaCjDOg6XK_7TvNQGn_2aqyAjYrlNI82qNbhat2MC0F7N-JUTZa6D-oWkheb1OEuk92WUaKw3Q6z2vn28S6gqpHO_z5sQHkxW6pL2BVfKIhZE0qEDpuZ0ulyzLLSb0Kl0x0MR_jUJ89Yvj8NvgE5ud-r |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JTsMwEB1BQdALSwFRKBAEHEBETRwnTg4IlUAFoq04FKm3EDvOCbWlC4if4hsZZ2lBQr31wM2SLdvyex4_bzMAp5SISMaRpXuUOzqNmNB5SKge2xYlhhdzT0RJsAnWarmdjve0AF_5Xxj1rDK3iYmhjnpCnZFXcZlV6pea3nX_TVdRo9Ttah5CI6XFo_z8wC3b8OrhFvE9I6R-1_bv9SyqgC6o5WAv3JCTkDHpchZL4sWSESKEE4WCU1eaQl1eohKwuGkYknHKJDUpD21OUSqYwsJ6F2EJ7ThTmz3WYVPLz1jqo9NgOgonO3WHauGcqYoQhwflv01_L4BTVftTGyeLW339vw3LBqxlMlqrpbzfhAXZLcFKM3soUIKiEtGpD-otOLxRL-9Hmq8YPtCmWZcatkW24XkuXd2BQrfXlbug2YZwTDdiVowEtbAuTEqUZMhclIJOVIbzHKxAZE7TVeyO1wA3TwrYQAEbJMCW4WRStp-6CvmzVCUHMsjMxTCYoliG40k2TnR1exN2ZW-syuDcQXFmkjJcJFyZ0Urg12p-ktqb3d4RrN63m42g8dB63IeiGvX0p2UFCqPBWB7AsnhHUAaHCdU1eJk3ib4BYho2Cw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7olOGLd7FeZkVfFIttkjbt46wORR17UNhbaS59km3Mzd_vOW23KYggvgV60jT5zkm-NMkXgHPBtLGF4V4iVOQJI7Wncia8IuSC-UmhEm3KyyZktxv3-0mv3ptDZ2EqfYj5DzeKjLK_pgC3I1NQlHN0QkRR51giMupQLMOKCLGTJWFn0Vt0xFJWkpm-9JDHhJU6KeW-XuT9Ph4tSOZXqlqONZ2Nf37lJqzXJNNtV16xBUt2sA3N53oZfQdaN7QVfeKmBPnYJcJZ6TVfuQxH21147dy9pPdefVGCpwWPsGHjXLFcShsrWViWFFYypnVkcq1EbANN67FIbrgKfN9KJaQVgVB5qASyn0DzPWgMhgO7D27o6yiIjeQFIsbxXZi0yFEQSuRGkXHgYtZcma5VxOkyi7cMZxNU5YwqnJUVduBsbjuqtDN-tDqatXpWx897hqSK5joiSBw4nT9Gz6fljHxgh1OyQWdCthIwBy5LDH4pJUvb7bRMHfzF-ASavdtO9vTQfTyENYKgOod4BI3JeGqPYVV_IELjVul5n-w41qc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Breast+Cancer+Statistics%2C+2022&rft.jtitle=CA%3A+a+cancer+journal+for+clinicians&rft.au=Giaquinto%2C+Angela+N&rft.au=Sung%2C+Hyuna&rft.au=Miller%2C+Kimberly+D&rft.au=Kramer%2C+Joan+L&rft.date=2022-11-01&rft.issn=1542-4863&rft.eissn=1542-4863&rft.volume=72&rft.issue=6&rft.spage=524&rft_id=info:doi/10.3322%2Fcaac.21754&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-9235&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-9235&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-9235&client=summon |